| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 BRIP1 PER1 GATA6 AHDC1 MEF2C GATAD2B PHC3 BEND6 SALL1 BRCA1 NFATC1 GLI2 BAHCC1 SFMBT1 GRWD1 FOS FANCM SIRT1 NCOR2 ASXL3 ANKRD17 FOXP1 CBX8 | 3.13e-07 | 739 | 197 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | GTPase activator activity | RALGAPA1 AGAP5 ARHGAP24 TAGAP TBC1D12 ARHGAP20 SIPA1L1 DEPDC5 ARHGAP33 EVI5L MTSS2 SOS1 | 2.24e-05 | 279 | 197 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RALGAPA1 AGAP5 ARHGAP24 TAGAP FGD4 TBC1D12 FGD1 HERC1 ARHGAP20 SIPA1L1 DEPDC5 FGD6 ARHGAP33 EVI5L MTSS2 SOS1 | 4.56e-05 | 507 | 197 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RALGAPA1 AGAP5 ARHGAP24 TAGAP FGD4 TBC1D12 FGD1 HERC1 ARHGAP20 SIPA1L1 DEPDC5 FGD6 ARHGAP33 EVI5L MTSS2 SOS1 | 4.56e-05 | 507 | 197 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3K14 deacetylase activity, hydrolytic mechanism | 9.68e-05 | 2 | 197 | 2 | GO:0031078 | |
| GeneOntologyMolecularFunction | histone H3K9 deacetylase activity, hydrolytic mechanism | 2.89e-04 | 3 | 197 | 2 | GO:0032129 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.86e-04 | 140 | 197 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone H4K deacetylase activity | 5.74e-04 | 4 | 197 | 2 | GO:0141051 | |
| GeneOntologyMolecularFunction | histone H3K deacetylase activity | 5.74e-04 | 4 | 197 | 2 | GO:0141050 | |
| GeneOntologyMolecularFunction | histone H4K16 deacetylase activity, hydrolytic mechanism | 5.74e-04 | 4 | 197 | 2 | GO:0034739 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 5.74e-04 | 4 | 197 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MYC HDAC9 SETD1A ASXL1 PER1 GATA6 SIK1 MEF2C SALL1 NFATC1 RBBP8 FOS SIRT1 NCOR2 FOXP1 | 6.88e-04 | 582 | 197 | 15 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | HDAC9 SETD1A ASXL1 GATA6 MEF2C SALL1 NFATC1 RBBP8 FOS SIRT1 NCOR2 FOXP1 | 9.28e-04 | 417 | 197 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 9.50e-04 | 5 | 197 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SRPK1 SIK1 PASK MAST4 MAP3K9 EIF2AK3 WNK3 LRRK1 TESK1 TNNI3K DYRK1B | 9.97e-04 | 363 | 197 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | transcription factor binding | MYC HDAC9 SETD1A ASXL1 PER1 GATA6 SIK1 MEF2C BPTF SALL1 NFATC1 RBBP8 FOS PCLO SIRT1 NCOR2 FOXP1 | 1.32e-03 | 753 | 197 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | SUMO polymer binding | 1.42e-03 | 6 | 197 | 2 | GO:0032184 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | MYC SP2 PER1 GATA6 IKZF1 MEF2C HOXA1 ZIC4 BPTF HOXB1 SALL1 NFATC1 GLI2 NR1D2 IKZF2 FOS SIRT1 MTF1 ZNF335 SP9 ELF1 FOXP1 GLIS1 ELL | 1.70e-03 | 1271 | 197 | 24 | GO:0000987 |
| GeneOntologyBiologicalProcess | embryo development | MYC EPOR SP2 KIF1B GATA6 PTCH1 AHDC1 MEF2C HOXA1 BPTF HOXB1 HEG1 SALL1 BRCA1 CDC40 GLI2 BRPF1 SEC24B FGFR1 FGFR2 CPLANE1 RBBP8 SOBP PKDCC LAMA4 VPS54 SPECC1 NCOR2 CELSR1 LRIG1 MTHFR ZNF335 TTLL4 SP9 FOXP1 ELL PHLDB2 SOS1 | 8.36e-09 | 1437 | 197 | 38 | GO:0009790 |
| GeneOntologyBiologicalProcess | central nervous system development | EPOR SETD1A RTN3 IKZF1 PTCH1 TNFRSF21 HOXA1 ZIC4 BPTF HOXB1 KIRREL3 SALL1 GLI2 SEC24B FGFR1 FGFR2 TACC3 HERC1 CPLANE1 CUL4B KIF27 DUSP15 VPS54 SLC1A1 NCOR2 CELSR1 MTF1 ZNF335 FOXP1 KDM4A TNFRSF1B VPS13B SOS1 | 3.55e-08 | 1197 | 197 | 33 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MYC RALGAPA1 HDAC9 SP2 MAGEB1 PER1 GATA6 SIK1 IKZF1 PTCH1 MEF2C GATAD2B BPTF PHC3 ZNF469 BEND6 SALL1 BRCA1 NFATC1 GLI2 FGFR1 FGFR2 MAGEC1 NR1D2 SFMBT1 RBBP8 DUSP15 MAGEE1 SIRT1 NCOR2 MAGEB5 FOXP1 KDM4A GLIS1 CBX8 | 1.40e-07 | 1399 | 197 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MYC RALGAPA1 HDAC9 SP2 MAGEB1 PER1 GATA6 SIK1 IKZF1 PTCH1 MEF2C GATAD2B BPTF PHC3 ZNF469 BEND6 SALL1 BRCA1 NFATC1 GLI2 FGFR1 FGFR2 MAGEC1 NR1D2 SFMBT1 RBBP8 DUSP15 MAGEE1 SIRT1 NCOR2 MAGEB5 FOXP1 KDM4A GLIS1 CBX8 | 1.78e-07 | 1413 | 197 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | heart development | HDAC9 EPOR ASXL1 GATA6 SIK1 PTCH1 MEF2C SMYD4 HEG1 SALL1 NFATC1 GLI2 SEC24B FGFR1 FGFR2 CPLANE1 PRICKLE4 ANK2 APC SIRT1 NCOR2 FOXP1 TNFRSF1B SOS1 | 2.70e-07 | 757 | 197 | 24 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MYC RALGAPA1 HDAC9 SP2 MAGEB1 PER1 GATA6 SIK1 IKZF1 PTCH1 MEF2C GATAD2B BPTF ZNF469 SALL1 NFATC1 GLI2 FGFR1 FGFR2 MAGEC1 NR1D2 DUSP15 MAGEE1 SIRT1 NCOR2 MAGEB5 FOXP1 GLIS1 CBX8 | 2.73e-07 | 1053 | 197 | 29 | GO:0000122 |
| GeneOntologyBiologicalProcess | chromatin organization | MYC HDAC9 SETD1A ASXL1 PADI4 PER1 SRPK1 IKZF1 RAD54L2 GATAD2B BPTF BRCA1 UBR5 BRPF1 BRD1 BAHCC1 SFMBT1 GRWD1 ZDBF2 TEX15 SIRT1 MTHFR ZNF335 KDM4A CBX8 | 1.57e-06 | 896 | 197 | 25 | GO:0006325 |
| GeneOntologyBiologicalProcess | circulatory system development | HDAC9 EPOR SP2 ASXL1 ARHGAP24 GATA6 SIK1 PTCH1 MEF2C HOXA1 SMYD4 HEG1 SALL1 BRCA1 NFATC1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 CPLANE1 EIF2AK3 PRICKLE4 ANK2 APC LAMA4 SLC1A1 SIRT1 NCOR2 ANKRD17 FOXP1 TNFRSF1B SOS1 | 2.43e-06 | 1442 | 197 | 33 | GO:0072359 |
| GeneOntologyBiologicalProcess | brain development | EPOR SETD1A RTN3 IKZF1 PTCH1 HOXA1 BPTF HOXB1 KIRREL3 SALL1 GLI2 SEC24B FGFR1 FGFR2 TACC3 HERC1 CPLANE1 KIF27 SLC1A1 NCOR2 ZNF335 FOXP1 VPS13B SOS1 | 2.52e-06 | 859 | 197 | 24 | GO:0007420 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SP2 KIF1B GATA6 PTCH1 MEF2C HOXA1 BPTF HOXB1 HEG1 SALL1 BRCA1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 RBBP8 VPS54 SPECC1 NCOR2 CELSR1 MTHFR ZNF335 TTLL4 ELL | 2.98e-06 | 929 | 197 | 25 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | MYC GATA6 PTCH1 AHDC1 MEF2C HOXA1 HOXB1 SALL1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 CPLANE1 SOBP CELSR1 LRIG1 MTHFR SP9 PHLDB2 SOS1 | 5.02e-06 | 713 | 197 | 21 | GO:0048598 |
| GeneOntologyBiologicalProcess | chordate embryonic development | SP2 GATA6 PTCH1 MEF2C HOXA1 BPTF HOXB1 HEG1 SALL1 BRCA1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 RBBP8 VPS54 SPECC1 NCOR2 CELSR1 MTHFR ZNF335 TTLL4 ELL | 6.24e-06 | 906 | 197 | 24 | GO:0043009 |
| GeneOntologyBiologicalProcess | head development | EPOR SETD1A RTN3 IKZF1 PTCH1 HOXA1 BPTF HOXB1 KIRREL3 SALL1 GLI2 SEC24B FGFR1 FGFR2 TACC3 HERC1 CPLANE1 KIF27 SLC1A1 NCOR2 ZNF335 FOXP1 VPS13B SOS1 | 7.92e-06 | 919 | 197 | 24 | GO:0060322 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.00e-05 | 109 | 197 | 8 | GO:0090630 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MYC HDAC9 SETD1A ASXL1 PADI4 PER1 SRPK1 IKZF1 RAD54L2 GATAD2B BPTF BRCA1 UBR5 BRPF1 BRD1 BAHCC1 SFMBT1 GRWD1 ZDBF2 TEX15 SIRT1 MTHFR ZNF335 KDM4A CBX8 | 1.05e-05 | 999 | 197 | 25 | GO:0071824 |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 1.07e-05 | 110 | 197 | 8 | GO:0014855 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | MYC EPOR ARHGAP24 PTCH1 AHDC1 MEF2C HEG1 SALL1 NFATC1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 CPLANE1 APC CELSR1 MTHFR FOXP1 PHLDB2 SOS1 | 1.08e-05 | 750 | 197 | 21 | GO:0048729 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.77e-05 | 154 | 197 | 9 | GO:0042471 | |
| GeneOntologyBiologicalProcess | muscle structure development | MYC HDAC9 EPOR GATA6 SIK1 DTNBP1 MEF2C HEG1 NFATC1 FGFR2 NR1D2 SFMBT1 PRICKLE4 ANK2 FOS VPS54 SIRT1 DYRK1B ANKRD17 FOXP1 TANC1 VPS13B | 2.57e-05 | 858 | 197 | 22 | GO:0061061 |
| GeneOntologyBiologicalProcess | embryonic organ development | MYC SP2 PTCH1 MEF2C HOXA1 BPTF HOXB1 SALL1 CDC40 GLI2 SEC24B FGFR1 FGFR2 SOBP PKDCC CELSR1 LRIG1 | 2.92e-05 | 561 | 197 | 17 | GO:0048568 |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 3.41e-05 | 129 | 197 | 8 | GO:0042472 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell proliferation | 3.64e-05 | 65 | 197 | 6 | GO:0060043 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 3.79e-05 | 40 | 197 | 5 | GO:0033144 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.86e-05 | 212 | 197 | 10 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle tissue growth | 4.93e-05 | 100 | 197 | 7 | GO:0055021 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 5.52e-05 | 138 | 197 | 8 | GO:0055017 | |
| GeneOntologyBiologicalProcess | lung development | ASXL1 GATA6 HEG1 GLI2 SEC24B FGFR1 FGFR2 PKDCC NCOR2 CELSR1 FOXP1 | 5.84e-05 | 269 | 197 | 11 | GO:0030324 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MYC ASXL1 STRA8 PER1 GATA6 IKZF1 RAD54L2 MEF2C HOXA1 BPTF HOXB1 SALL1 CSRNP2 BRCA1 NFATC1 GLI2 FGFR1 FGFR2 NR1D2 IKZF2 FOS SIRT1 MTF1 ASXL3 ZNF335 ELF1 FOXP1 GLIS1 ELL | 5.86e-05 | 1390 | 197 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | heart morphogenesis | EPOR ASXL1 GATA6 PTCH1 MEF2C HEG1 NFATC1 SEC24B FGFR2 APC NCOR2 SOS1 | 6.41e-05 | 321 | 197 | 12 | GO:0003007 |
| GeneOntologyBiologicalProcess | respiratory tube development | ASXL1 GATA6 HEG1 GLI2 SEC24B FGFR1 FGFR2 PKDCC NCOR2 CELSR1 FOXP1 | 6.67e-05 | 273 | 197 | 11 | GO:0030323 |
| GeneOntologyBiologicalProcess | tube development | MYC HDAC9 EPOR ASXL1 ARHGAP24 BRIP1 GATA6 PTCH1 MEF2C HOXA1 HEG1 SALL1 BRCA1 NFATC1 GLI2 BRPF1 SEC24B SCAPER FGFR1 FGFR2 EIF2AK3 PKDCC SLC1A1 SIRT1 NCOR2 CELSR1 MTHFR FOXP1 SOS1 | 6.82e-05 | 1402 | 197 | 29 | GO:0035295 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 7.45e-05 | 185 | 197 | 9 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 7.45e-05 | 185 | 197 | 9 | GO:0035108 | |
| GeneOntologyBiologicalProcess | regulation of heart growth | 7.59e-05 | 107 | 197 | 7 | GO:0060420 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | MYC EPOR ASXL1 GATA6 IKZF1 PTCH1 AHDC1 MEF2C HOXA1 HOXB1 HEG1 SALL1 NFATC1 GLI2 SEC24B FGD1 FGFR1 FGFR2 SOBP APC SLC1A1 NCOR2 CELSR1 LRIG1 ASXL3 ZNF335 SOS1 | 7.81e-05 | 1269 | 197 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | muscle organ development | MYC HDAC9 EPOR DTNBP1 MEF2C HEG1 FGFR2 NR1D2 SFMBT1 FOS VPS54 SIRT1 FOXP1 VPS13B | 8.18e-05 | 436 | 197 | 14 | GO:0007517 |
| GeneOntologyBiologicalProcess | heart growth | 9.04e-05 | 148 | 197 | 8 | GO:0060419 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 9.08e-05 | 2 | 197 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYC HDAC9 SETD1A PADI4 PER1 RAD54L2 GATAD2B BPTF BRCA1 UBR5 BRPF1 BRD1 GRWD1 ZDBF2 TEX15 SIRT1 ZNF335 KDM4A CBX8 | 9.39e-05 | 741 | 197 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | MYC RALGAPA1 AGAP5 ARHGAP24 APC2 MEF2C TBC1D12 FGFR1 FGFR2 EIF2AK3 SLC1A1 SIRT1 SIPA1L1 EVI5L MTSS2 | 9.51e-05 | 499 | 197 | 15 | GO:0051345 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | MYC ARHGAP24 PTCH1 MEF2C SALL1 NFATC1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 CPLANE1 CELSR1 MTHFR FOXP1 PHLDB2 SOS1 | 9.81e-05 | 619 | 197 | 17 | GO:0002009 |
| GeneOntologyBiologicalProcess | molting cycle | 9.93e-05 | 150 | 197 | 8 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 9.93e-05 | 150 | 197 | 8 | GO:0042633 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 1.35e-04 | 82 | 197 | 6 | GO:0060038 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.44e-04 | 83 | 197 | 6 | GO:0060976 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte proliferation | 1.59e-04 | 29 | 197 | 4 | GO:0010839 | |
| GeneOntologyBiologicalProcess | respiratory system development | ASXL1 GATA6 HEG1 GLI2 SEC24B FGFR1 FGFR2 PKDCC NCOR2 CELSR1 FOXP1 | 1.77e-04 | 305 | 197 | 11 | GO:0060541 |
| GeneOntologyBiologicalProcess | muscle adaptation | 1.84e-04 | 164 | 197 | 8 | GO:0043500 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | MYC HDAC9 EPOR ARHGAP24 GATA6 PTCH1 MEF2C HOXA1 HEG1 SALL1 BRCA1 NFATC1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 EIF2AK3 SLC1A1 SIRT1 CELSR1 MTHFR FOXP1 SOS1 | 1.93e-04 | 1125 | 197 | 24 | GO:0035239 |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle tissue growth | 1.94e-04 | 56 | 197 | 5 | GO:0055023 | |
| GeneOntologyBiologicalProcess | lateral sprouting from an epithelium | 2.29e-04 | 13 | 197 | 3 | GO:0060601 | |
| GeneOntologyBiologicalProcess | kidney development | MYC ASXL1 PTCH1 DTNBP1 MEF2C KIRREL3 SALL1 GLI2 FGFR1 FGFR2 CPLANE1 APC | 2.54e-04 | 372 | 197 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | response to retinoic acid | 2.68e-04 | 131 | 197 | 7 | GO:0032526 | |
| GeneOntologyBiologicalProcess | positive regulation of heart growth | 2.69e-04 | 60 | 197 | 5 | GO:0060421 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage apoptotic process | 2.71e-04 | 3 | 197 | 2 | GO:2000111 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 2.71e-04 | 3 | 197 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 2.71e-04 | 3 | 197 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | rhombomere 4 development | 2.71e-04 | 3 | 197 | 2 | GO:0021570 | |
| GeneOntologyBiologicalProcess | facial nucleus development | 2.71e-04 | 3 | 197 | 2 | GO:0021754 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | MYC RALGAPA1 AGAP5 ARHGAP24 APC2 MEF2C FGD4 TBC1D12 FGD1 FGFR1 FGFR2 EIF2AK3 CAST SLC1A1 SIRT1 FETUB SIPA1L1 FGD6 EVI5L MTSS2 | 2.96e-04 | 878 | 197 | 20 | GO:0051336 |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 2.99e-04 | 34 | 197 | 4 | GO:0060977 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.08e-04 | 134 | 197 | 7 | GO:0003279 | |
| GeneOntologyBiologicalProcess | limb development | 3.14e-04 | 224 | 197 | 9 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 3.14e-04 | 224 | 197 | 9 | GO:0048736 | |
| GeneOntologyBiologicalProcess | muscle tissue development | MYC HDAC9 EPOR GATA6 SIK1 MEF2C HEG1 FGFR1 FGFR2 NR1D2 FOS APC VPS54 SIRT1 FOXP1 | 3.18e-04 | 558 | 197 | 15 | GO:0060537 |
| GeneOntologyBiologicalProcess | embryonic digestive tract development | 3.35e-04 | 35 | 197 | 4 | GO:0048566 | |
| GeneOntologyBiologicalProcess | renal system development | MYC ASXL1 PTCH1 DTNBP1 MEF2C KIRREL3 SALL1 GLI2 FGFR1 FGFR2 CPLANE1 APC | 3.54e-04 | 386 | 197 | 12 | GO:0072001 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.58e-04 | 228 | 197 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | pons development | 3.59e-04 | 15 | 197 | 3 | GO:0021548 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 3.74e-04 | 36 | 197 | 4 | GO:0002053 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 3.77e-04 | 99 | 197 | 6 | GO:0051145 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | RALGAPA1 AGAP5 ARHGAP24 APC2 FGD4 TBC1D12 FGD1 SIPA1L1 FGD6 EVI5L MTSS2 | 3.95e-04 | 335 | 197 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HDAC9 ARHGAP24 GATA6 PTCH1 AHDC1 MEF2C HOXA1 HOXB1 SALL1 BRCA1 NFATC1 GLI2 BRPF1 SEC24B FGFR1 FGFR2 HERC1 EIF2AK3 KNL1 ANK2 SLC1A1 SIRT1 CELSR1 MTHFR DYRK1B TANC1 VPS13B PHLDB2 | 4.16e-04 | 1483 | 197 | 28 | GO:0048646 |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 4.37e-04 | 142 | 197 | 7 | GO:0003300 | |
| GeneOntologyBiologicalProcess | tube formation | 4.46e-04 | 187 | 197 | 8 | GO:0035148 | |
| GeneOntologyBiologicalProcess | regulation of organ growth | 4.56e-04 | 143 | 197 | 7 | GO:0046620 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle cell proliferation | 4.62e-04 | 38 | 197 | 4 | GO:0060045 | |
| GeneOntologyBiologicalProcess | cell proliferation in forebrain | 4.62e-04 | 38 | 197 | 4 | GO:0021846 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | MYC IKZF1 HOXA1 GLI2 SEC24B FGFR1 FGFR2 SOBP SLC1A1 CELSR1 LRIG1 | 4.81e-04 | 343 | 197 | 11 | GO:0090596 |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 4.96e-04 | 190 | 197 | 8 | GO:0016331 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 5.17e-04 | 146 | 197 | 7 | GO:0014897 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 5.17e-04 | 105 | 197 | 6 | GO:0008589 | |
| GeneOntologyBiologicalProcess | negative regulation of androgen receptor signaling pathway | 5.29e-04 | 17 | 197 | 3 | GO:0060766 | |
| GeneOntologyBiologicalProcess | rhombomere 5 development | 5.38e-04 | 4 | 197 | 2 | GO:0021571 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | HDAC9 EPOR GATA6 SIK1 MEF2C HEG1 FGFR1 FGFR2 APC SIRT1 FOXP1 | 5.55e-04 | 349 | 197 | 11 | GO:0014706 |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 5.60e-04 | 148 | 197 | 7 | GO:0014896 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | MYC MEF2C HOXA1 HOXB1 GLI2 SEC24B FGFR1 FGFR2 SOBP CELSR1 LRIG1 | 5.82e-04 | 351 | 197 | 11 | GO:0048562 |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 6.30e-04 | 18 | 197 | 3 | GO:0060979 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | SP2 GATA6 PTCH1 BPTF HEG1 GLI2 FGFR1 FGFR2 RBBP8 VPS54 SPECC1 NCOR2 ZNF335 TTLL4 ELL | 6.31e-04 | 596 | 197 | 15 | GO:0001701 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | HDAC9 ASXL1 BRIP1 PER1 GATA6 MEF2C BRCA1 UBR5 NR1D2 FOS APC VPS54 SIRT1 NCOR2 ZNF592 FOXP1 SOS1 | 6.34e-04 | 727 | 197 | 17 | GO:0032870 |
| GeneOntologyBiologicalProcess | positive regulation of organ growth | 6.70e-04 | 73 | 197 | 5 | GO:0046622 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 6.73e-04 | 199 | 197 | 8 | GO:0051147 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 6.80e-04 | 42 | 197 | 4 | GO:0045879 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | MYC HDAC9 BRIP1 STRA8 HROB BRCA1 NFATC1 UBR5 GLI2 FGFR1 CUL4B GRWD1 RBBP8 VPS54 TEX15 FANCM SIRT1 DYRK1B ANKRD17 FOXP1 CBX8 RNF111 | 6.82e-04 | 1081 | 197 | 22 | GO:0006259 |
| GeneOntologyBiologicalProcess | metencephalon development | 6.83e-04 | 153 | 197 | 7 | GO:0022037 | |
| GeneOntologyBiologicalProcess | negative regulation of protein serine/threonine kinase activity | 7.27e-04 | 112 | 197 | 6 | GO:0071901 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | MYC PTCH1 MEF2C SALL1 NFATC1 GLI2 BRPF1 SEC24B FGFR2 CELSR1 MTHFR FOXP1 | 7.63e-04 | 421 | 197 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 8.69e-04 | 312 | 197 | 10 | GO:0002573 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 8.85e-04 | 45 | 197 | 4 | GO:0010464 | |
| GeneOntologyBiologicalProcess | acinar cell proliferation | 8.91e-04 | 5 | 197 | 2 | GO:1990863 | |
| GeneOntologyCellularComponent | chromatin | MYC SETD1A SP2 TSHZ2 GATA6 SRPK1 IKZF1 MEF2C GATAD2B HOXA1 BPTF HOXB1 SALL1 CSRNP2 NFATC1 UBR5 BRPF1 BRD1 NR1D2 HOMEZ FOS ICE1 FANCM SIRT1 NCOR2 ANKRD17 SP9 ELF1 FOXP1 KDM4A ELL CBX8 | 9.63e-06 | 1480 | 198 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | PcG protein complex | 1.31e-04 | 52 | 198 | 5 | GO:0031519 | |
| GeneOntologyCellularComponent | nuclear body | MYC EPOR SETD1A SRPK1 RAD54L2 MEF2C GATAD2B BRCA1 CDC40 NFATC1 GLI2 SCAPER BRD1 KNL1 ICE1 SIRT1 NCOR2 COIL ELL RNF111 | 3.82e-04 | 903 | 198 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | PR-DUB complex | 5.29e-04 | 4 | 198 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | histone locus body | 5.29e-04 | 4 | 198 | 2 | GO:0035363 | |
| GeneOntologyCellularComponent | BRCA1-B complex | 5.29e-04 | 4 | 198 | 2 | GO:0070532 | |
| GeneOntologyCellularComponent | euchromatin | 6.06e-04 | 72 | 198 | 5 | GO:0000791 | |
| GeneOntologyCellularComponent | postsynapse | LHFPL4 KIF1B APC2 RTN3 DTNBP1 MEF2C LRFN5 KCTD16 FGFR1 TACC3 ANK2 PCLO CAST APC MAGEE1 GABBR2 SLC1A1 SIPA1L1 TANC1 AKAP1 ARHGAP33 | 6.88e-04 | 1018 | 198 | 21 | GO:0098794 |
| HumanPheno | Slanting of the palpebral fissure | SETD1A ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF BRCA1 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 EIF2AK3 KNL1 CUL4B RBBP8 PKDCC APC GABBR2 FANCM ASXL3 ANKRD17 FOXP1 VPS13B MTSS2 SOS1 | 2.34e-08 | 739 | 77 | 31 | HP:0200006 |
| HumanPheno | Abnormality of the forehead | RALGAPA1 SETD1A ASXL1 BRIP1 APC2 GATA6 PEX1 SIK1 PTCH1 MEF2C GATAD2B HOXB1 BRCA1 GLI2 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 KNL1 CUL4B RBBP8 FOS PKDCC APC GABBR2 FANCM ASXL3 ZNF335 ANKRD17 FOXP1 DEPDC5 BSCL2 EDA2R VPS13B TCTN2 MTSS2 SOS1 | 6.18e-08 | 1208 | 77 | 40 | HP:0000290 |
| HumanPheno | Abnormality of the palpebral fissures | SETD1A ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF SALL1 BRCA1 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 EIF2AK3 KNL1 CUL4B RBBP8 PCLO PKDCC APC GABBR2 FANCM ASXL3 ANKRD17 FOXP1 VPS13B MTSS2 SOS1 | 1.07e-07 | 880 | 77 | 33 | HP:0008050 |
| HumanPheno | Abnormal eyelid morphology | SETD1A ASXL1 BRIP1 APC2 PEX1 IKZF1 PTCH1 AHDC1 MEF2C GATAD2B BPTF HOXB1 ZNF469 SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 KNL1 CUL4B RBBP8 PCLO PKDCC APC GABBR2 FANCM ASXL3 IGHM ANKRD17 FOXP1 DEPDC5 TNFRSF1B VPS13B MTSS2 SOS1 | 4.93e-07 | 1408 | 77 | 42 | HP:0000492 |
| HumanPheno | Upslanted palpebral fissure | ASXL1 BRIP1 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF BRCA1 FGFR1 FGFR2 HERC1 EIF2AK3 KNL1 FANCM ASXL3 ANKRD17 MTSS2 | 1.41e-06 | 333 | 77 | 18 | HP:0000582 |
| HumanPheno | Abnormality of globe location or size | RALGAPA1 SETD1A ASXL1 BRIP1 GATA6 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 KNL1 RBBP8 PCLO PKDCC APC FANCM MTHFR ASXL3 IGHM ANKRD17 FOXP1 DEPDC5 VPS13B TCTN2 SOS1 | 1.68e-06 | 1246 | 77 | 38 | HP:0000489 |
| HumanPheno | Abnormality of the outer ear | RALGAPA1 HDAC9 SETD1A ASXL1 BRIP1 GATA6 PEX1 PTCH1 AHDC1 MEF2C BPTF HOXB1 SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 CUL4B RBBP8 PCLO APC ARMC9 FANCM MTHFR ASXL3 IGHM FOXP1 DEPDC5 BSCL2 VPS13B TCTN2 SOS1 | 3.54e-06 | 1337 | 77 | 39 | HP:0000356 |
| HumanPheno | Abnormality of globe location | RALGAPA1 SETD1A ASXL1 BRIP1 GATA6 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 KNL1 PCLO PKDCC APC FANCM MTHFR ASXL3 IGHM ANKRD17 FOXP1 DEPDC5 TCTN2 SOS1 | 3.57e-06 | 1122 | 77 | 35 | HP:0100886 |
| HumanPheno | Hypertelorism | SETD1A ASXL1 BRIP1 GATA6 PEX1 PTCH1 AHDC1 MEF2C GATAD2B BPTF BRCA1 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 KNL1 APC FANCM ASXL3 IGHM FOXP1 DEPDC5 TCTN2 SOS1 | 4.33e-06 | 830 | 77 | 29 | HP:0000316 |
| HumanPheno | Abnormality of calvarial morphology | RALGAPA1 SETD1A ASXL1 BRIP1 APC2 GATA6 PEX1 PTCH1 AHDC1 MEF2C GATAD2B HOXB1 BRCA1 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B RBBP8 PCLO PKDCC APC ARMC9 GABBR2 FANCM MTHFR ASXL3 ANKRD17 DEPDC5 EDA2R TCTN2 SOS1 | 4.61e-06 | 1134 | 77 | 35 | HP:0002648 |
| HumanPheno | Abnormal hand morphology | ASXL1 BRIP1 APC2 GATA6 PEX1 SIK1 PTCH1 MEF2C BPTF SALL1 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 CUL4B RBBP8 FOS PKDCC APC ARMC9 GABBR2 FANCM ASXL3 BSCL2 EDA2R VPS13B TCTN2 SOS1 | 4.63e-06 | 1082 | 77 | 34 | HP:0005922 |
| HumanPheno | Abnormality of the jaws | HDAC9 ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 KNL1 CUL4B RBBP8 SOBP FOS PKDCC APC ARMC9 FANCM ASXL3 ZNF335 FOXP1 BSCL2 VPS13B TCTN2 SOS1 | 1.07e-05 | 1175 | 77 | 35 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | HDAC9 ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 KNL1 CUL4B RBBP8 SOBP FOS PKDCC APC ARMC9 FANCM ASXL3 ZNF335 FOXP1 BSCL2 VPS13B TCTN2 SOS1 | 1.10e-05 | 1176 | 77 | 35 | HP:0030791 |
| HumanPheno | Abnormal pinna morphology | RALGAPA1 HDAC9 SETD1A ASXL1 BRIP1 PEX1 PTCH1 AHDC1 MEF2C BPTF HOXB1 SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B RBBP8 PCLO APC ARMC9 FANCM MTHFR ASXL3 IGHM FOXP1 DEPDC5 BSCL2 VPS13B TCTN2 SOS1 | 1.45e-05 | 1299 | 77 | 37 | HP:0000377 |
| HumanPheno | Anterior bulging of the globe | ASXL1 BRIP1 GATA6 PTCH1 BRCA1 FGFR1 FGFR2 HERC1 PCLO PKDCC APC FANCM MTHFR ASXL3 SOS1 | 1.58e-05 | 283 | 77 | 15 | HP:0000644 |
| HumanPheno | Proptosis | ASXL1 BRIP1 GATA6 PTCH1 BRCA1 FGFR1 FGFR2 HERC1 PCLO PKDCC APC FANCM MTHFR ASXL3 SOS1 | 1.58e-05 | 283 | 77 | 15 | HP:0000520 |
| HumanPheno | Abnormal calvaria morphology | RALGAPA1 SETD1A ASXL1 BRIP1 APC2 GATA6 PEX1 PTCH1 AHDC1 MEF2C GATAD2B HOXB1 BRCA1 GLI2 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B RBBP8 PCLO PKDCC APC ARMC9 GABBR2 FANCM MTHFR ASXL3 ANKRD17 DEPDC5 EDA2R TCTN2 SOS1 | 1.74e-05 | 1254 | 77 | 36 | HP:0002683 |
| HumanPheno | Abnormal toe morphology | ASXL1 BRIP1 KIF1B APC2 GATA6 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF ZNF469 SALL1 BRCA1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 CUL4B RBBP8 APC ARMC9 FANCM ASXL3 BSCL2 VPS13B TCTN2 | 1.90e-05 | 893 | 77 | 29 | HP:0001780 |
| HumanPheno | Abnormal midface morphology | HDAC9 SETD1A ASXL1 GATA6 PEX1 PTCH1 BPTF HOXB1 SALL1 GLI2 FGD1 FGFR1 FGFR2 HERC1 EIF2AK3 SOBP PCLO APC ASXL3 ANKRD17 FOXP1 DEPDC5 VPS13B TCTN2 SOS1 | 2.04e-05 | 704 | 77 | 25 | HP:0000309 |
| HumanPheno | Strabismus | ASXL1 BRIP1 APC2 PEX1 SIK1 PTCH1 AHDC1 MEF2C GATAD2B HOXA1 BPTF HOXB1 SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 WNK3 SOBP APC ARMC9 FANCM ASXL3 RP1L1 ANKRD17 FOXP1 VPS13B TCTN2 SOS1 | 2.25e-05 | 1159 | 77 | 34 | HP:0000486 |
| HumanPheno | Choanal atresia or stenosis | 2.77e-05 | 134 | 77 | 10 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 2.77e-05 | 134 | 77 | 10 | HP:0000415 | |
| HumanPheno | Abnormal mandible morphology | HDAC9 ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 BRCA1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 KNL1 CUL4B RBBP8 FOS PKDCC APC ARMC9 FANCM ASXL3 ZNF335 FOXP1 BSCL2 VPS13B TCTN2 SOS1 | 2.85e-05 | 1118 | 77 | 33 | HP:0000277 |
| HumanPheno | Downslanted palpebral fissures | SETD1A APC2 PTCH1 AHDC1 BPTF BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CUL4B RBBP8 PKDCC APC GABBR2 ASXL3 FOXP1 VPS13B SOS1 | 3.06e-05 | 497 | 77 | 20 | HP:0000494 |
| HumanPheno | Abnormal nasal bridge morphology | RALGAPA1 ASXL1 APC2 PEX1 SIK1 PTCH1 AHDC1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 CUL4B PCLO PKDCC ARMC9 MTHFR ASXL3 ZNF335 VPS13B TCTN2 SOS1 | 3.90e-05 | 1029 | 77 | 31 | HP:0000422 |
| HumanPheno | Abnormal conjugate eye movement | ASXL1 BRIP1 APC2 PEX1 SIK1 PTCH1 AHDC1 MEF2C GATAD2B HOXA1 BPTF HOXB1 SALL1 BRCA1 GLI2 BRPF1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 WNK3 SOBP APC ARMC9 FANCM ASXL3 RP1L1 ANKRD17 FOXP1 VPS13B TCTN2 SOS1 | 4.68e-05 | 1198 | 77 | 34 | HP:0000549 |
| HumanPheno | Abnormal shape of the frontal region | SETD1A BRIP1 GATA6 PEX1 PTCH1 MEF2C GATAD2B HOXB1 BRCA1 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B APC GABBR2 FANCM MTHFR DEPDC5 EDA2R TCTN2 SOS1 | 4.94e-05 | 741 | 77 | 25 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | SETD1A BRIP1 GATA6 PEX1 PTCH1 MEF2C GATAD2B HOXB1 BRCA1 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B APC GABBR2 FANCM MTHFR DEPDC5 EDA2R TCTN2 SOS1 | 5.06e-05 | 742 | 77 | 25 | HP:0430000 |
| HumanPheno | Anteverted nares | RALGAPA1 SETD1A ASXL1 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 APC ARMC9 ASXL3 FOXP1 TCTN2 | 5.17e-05 | 559 | 77 | 21 | HP:0000463 |
| HumanPheno | Upturned nose | RALGAPA1 SETD1A ASXL1 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 APC ARMC9 ASXL3 FOXP1 TCTN2 | 5.17e-05 | 559 | 77 | 21 | HP:0000427 |
| HumanPheno | Toe syndactyly | BRIP1 APC2 MEF2C SALL1 BRCA1 FGFR1 FGFR2 CPLANE1 CUL4B RBBP8 APC ARMC9 FANCM | 6.00e-05 | 244 | 77 | 13 | HP:0001770 |
| HumanPheno | Epicanthus | SETD1A ASXL1 BRIP1 PEX1 PTCH1 GATAD2B BPTF HOXB1 ZNF469 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 WNK3 CUL4B FANCM ASXL3 IGHM MTSS2 SOS1 | 6.71e-05 | 614 | 77 | 22 | HP:0000286 |
| HumanPheno | Abnormality of the frontal hairline | RALGAPA1 ASXL1 APC2 PEX1 BRCA1 FGD1 FGFR2 FOS ANKRD17 BSCL2 VPS13B SOS1 | 7.62e-05 | 215 | 77 | 12 | HP:0000599 |
| HumanPheno | Abnormal nostril morphology | RALGAPA1 SETD1A ASXL1 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 APC ARMC9 ASXL3 FOXP1 TCTN2 | 7.85e-05 | 575 | 77 | 21 | HP:0005288 |
| HumanPheno | Choanal atresia | 8.42e-05 | 123 | 77 | 9 | HP:0000453 | |
| HumanPheno | Skin tags | 9.23e-05 | 97 | 77 | 8 | HP:0010609 | |
| HumanPheno | Shortening of all middle phalanges of the fingers | 1.11e-04 | 7 | 77 | 3 | HP:0006110 | |
| HumanPheno | Syndactyly | ASXL1 BRIP1 APC2 MEF2C SALL1 BRCA1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 CUL4B RBBP8 APC ARMC9 FANCM VPS13B | 1.18e-04 | 417 | 77 | 17 | HP:0001159 |
| HumanPheno | Abnormal morphology of the nasal alae | RALGAPA1 SETD1A ASXL1 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 APC ARMC9 ASXL3 ANKRD17 FOXP1 TCTN2 | 1.23e-04 | 639 | 77 | 22 | HP:0000429 |
| HumanPheno | Frontal bossing | SETD1A BRIP1 GATA6 PEX1 PTCH1 MEF2C GATAD2B HOXB1 BRCA1 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 WNK3 CUL4B APC GABBR2 FANCM DEPDC5 EDA2R TCTN2 SOS1 | 1.35e-04 | 738 | 77 | 24 | HP:0002007 |
| HumanPheno | Abnormal finger phalanx morphology | ASXL1 BRIP1 APC2 PEX1 SIK1 PTCH1 GATAD2B BPTF SALL1 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 CUL4B RBBP8 ARMC9 FANCM ASXL3 EDA2R TCTN2 | 1.35e-04 | 738 | 77 | 24 | HP:0005918 |
| HumanPheno | Large hands | 1.37e-04 | 34 | 77 | 5 | HP:0001176 | |
| HumanPheno | Abnormal periauricular region morphology | 1.37e-04 | 131 | 77 | 9 | HP:0000383 | |
| HumanPheno | Abnormal 5th finger morphology | BRIP1 GATA6 MEF2C BPTF SALL1 BRCA1 GLI2 SCAPER FGD1 FGFR2 CPLANE1 CUL4B RBBP8 PKDCC ARMC9 FANCM VPS13B TCTN2 SOS1 | 1.42e-04 | 509 | 77 | 19 | HP:0004207 |
| HumanPheno | Abnormality of the autonomic nervous system | BRIP1 KIF1B APC2 PTCH1 BRCA1 GLI2 SCAPER FGFR1 CPLANE1 ANK2 ARMC9 GABBR2 FANCM DEPDC5 TCTN2 | 1.63e-04 | 346 | 77 | 15 | HP:0002270 |
| HumanPheno | Expressive language delay | 1.75e-04 | 56 | 77 | 6 | HP:0002474 | |
| HumanPheno | Language delay | 1.75e-04 | 56 | 77 | 6 | HP:0002336 | |
| HumanPheno | Occipital meningocele | 1.76e-04 | 8 | 77 | 3 | HP:0002436 | |
| HumanPheno | Periauricular skin tag | 1.94e-04 | 81 | 77 | 7 | HP:0100278 | |
| HumanPheno | Preauricular skin tag | 1.94e-04 | 81 | 77 | 7 | HP:0000384 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | HDAC9 ASXL1 BRIP1 PEX1 SIK1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 SALL1 BRCA1 FGD4 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 WNK3 KNL1 CUL4B RBBP8 PKDCC APC ARMC9 GABBR2 FANCM ASXL3 ZNF335 BSCL2 EDA2R VPS13B TCTN2 SOS1 | 2.14e-04 | 1343 | 77 | 35 | HP:0009115 |
| HumanPheno | Broad proximal phalanx of the hallux | 2.26e-04 | 2 | 77 | 2 | HP:0010086 | |
| HumanPheno | 3-4 toe cutaneous syndactyly | 2.26e-04 | 2 | 77 | 2 | HP:6000648 | |
| HumanPheno | Broad middle phalanges of the toes | 2.26e-04 | 2 | 77 | 2 | HP:0010195 | |
| HumanPheno | Calcaneonavicular fusion | 2.26e-04 | 2 | 77 | 2 | HP:0008122 | |
| HumanPheno | Tracheal cartilaginous sleeve | 2.26e-04 | 2 | 77 | 2 | HP:0005347 | |
| HumanPheno | Abnormal external nose morphology | RALGAPA1 SETD1A ASXL1 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 KNL1 CUL4B RBBP8 APC ARMC9 ASXL3 ANKRD17 FOXP1 EDA2R VPS13B TCTN2 | 2.37e-04 | 916 | 77 | 27 | HP:0010938 |
| HumanPheno | Laryngomalacia | 2.44e-04 | 84 | 77 | 7 | HP:0001601 | |
| HumanPheno | Brachydactyly | ASXL1 BRIP1 APC2 GATA6 SIK1 PTCH1 GATAD2B BPTF SALL1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 CUL4B RBBP8 SLURP1 PKDCC APC EDA2R SOS1 | 2.47e-04 | 670 | 77 | 22 | HP:0001156 |
| HumanPheno | Short digit | ASXL1 BRIP1 APC2 GATA6 SIK1 PTCH1 GATAD2B BPTF SALL1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 CUL4B RBBP8 SLURP1 PKDCC APC EDA2R SOS1 | 2.58e-04 | 672 | 77 | 22 | HP:0011927 |
| HumanPheno | Abnormal cheek morphology | HDAC9 SETD1A ASXL1 GATA6 SALL1 GLI2 FGD1 FGFR1 FGFR2 EIF2AK3 PCLO VPS13B TCTN2 | 2.60e-04 | 282 | 77 | 13 | HP:0004426 |
| HumanPheno | Alobar holoprosencephaly | 2.61e-04 | 9 | 77 | 3 | HP:0006988 | |
| HumanPheno | Brachyturricephaly | 2.61e-04 | 9 | 77 | 3 | HP:0000244 | |
| HumanPheno | Macrocephaly | SETD1A APC2 PEX1 PTCH1 ZNF469 GLI2 FGD1 FGFR1 FGFR2 HERC1 CUL4B PKDCC APC GABBR2 ANKRD17 FOXP1 DEPDC5 SOS1 | 2.78e-04 | 491 | 77 | 18 | HP:0000256 |
| HumanPheno | Abnormality of the hypothalamus-pituitary axis | BRIP1 GATA6 PTCH1 BPTF BRCA1 GLI2 FGD1 FGFR1 CPLANE1 APC ARMC9 TEX15 FANCM MTHFR EDA2R VPS13B TCTN2 | 2.91e-04 | 449 | 77 | 17 | HP:0000864 |
| HumanPheno | Abnormal hair morphology | RALGAPA1 ASXL1 BRIP1 APC2 PEX1 PTCH1 DTNBP1 MEF2C GATAD2B BPTF ZNF469 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 KNL1 CUL4B RBBP8 FOS APC ARMC9 FANCM ASXL3 ANKRD17 FOXP1 DEPDC5 BSCL2 TNFRSF1B EDA2R VPS13B TCTN2 SOS1 | 3.09e-04 | 1424 | 77 | 36 | HP:0001595 |
| HumanPheno | Congenital abnormal hair pattern | RALGAPA1 ASXL1 APC2 PEX1 BRCA1 FGD1 FGFR2 FOS APC ANKRD17 FOXP1 BSCL2 VPS13B SOS1 | 3.17e-04 | 327 | 77 | 14 | HP:0011361 |
| HumanPheno | Abnormal duodenum morphology | 3.26e-04 | 88 | 77 | 7 | HP:0002246 | |
| HumanPheno | Acanthosis nigricans | 3.36e-04 | 63 | 77 | 6 | HP:0000956 | |
| HumanPheno | Abnormal corpus callosum morphology | RALGAPA1 ASXL1 APC2 PEX1 SIK1 PTCH1 AHDC1 MEF2C SALL1 CDC40 GLI2 BRPF1 FGFR1 FGFR2 HERC1 CPLANE1 KNL1 CUL4B PCLO ARMC9 GABBR2 MTHFR ASXL3 ZNF335 DEPDC5 VPS13B TCTN2 | 3.48e-04 | 937 | 77 | 27 | HP:0001273 |
| HumanPheno | Increased head circumference | SETD1A APC2 PEX1 PTCH1 ZNF469 GLI2 FGD1 FGFR1 FGFR2 HERC1 CUL4B PKDCC APC GABBR2 ANKRD17 FOXP1 DEPDC5 SOS1 | 3.48e-04 | 500 | 77 | 18 | HP:0040194 |
| HumanPheno | Abnormal skin morphology of the palm | ASXL1 PEX1 PTCH1 MEF2C ZNF469 FGD1 FGFR2 CAST SLURP1 PKDCC APC ASXL3 FOXP1 DEPDC5 TNFRSF1B VPS13B | 3.51e-04 | 413 | 77 | 16 | HP:0040211 |
| HumanPheno | Short philtrum | PTCH1 MEF2C GATAD2B BPTF HOXB1 GLI2 BRPF1 FGFR1 CUL4B APC ANKRD17 VPS13B | 3.55e-04 | 253 | 77 | 12 | HP:0000322 |
| HumanPheno | Finger syndactyly | BRIP1 SALL1 BRCA1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 APC FANCM VPS13B | 3.78e-04 | 218 | 77 | 11 | HP:0006101 |
| HumanPheno | Abnormality of the hairline | RALGAPA1 ASXL1 APC2 PEX1 BRCA1 FGD1 FGFR2 FOS APC ANKRD17 BSCL2 VPS13B SOS1 | 3.91e-04 | 294 | 77 | 13 | HP:0009553 |
| HumanPheno | Abnormal finger morphology | ASXL1 BRIP1 APC2 GATA6 PEX1 SIK1 PTCH1 MEF2C GATAD2B BPTF ZNF469 SALL1 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 WNK3 CUL4B RBBP8 PKDCC APC ARMC9 FANCM GAS2L2 ASXL3 FOXP1 EDA2R VPS13B TCTN2 SOS1 | 4.08e-04 | 1385 | 77 | 35 | HP:0001167 |
| HumanPheno | Abnormal facial shape | HDAC9 ASXL1 BRIP1 APC2 PEX1 PTCH1 AHDC1 BPTF SALL1 BRCA1 GLI2 BRPF1 FGD1 FGFR1 FGFR2 HERC1 CPLANE1 CUL4B RBBP8 FOS APC ARMC9 FANCM MTHFR ASXL3 ANKRD17 FOXP1 BSCL2 TNFRSF1B VPS13B TCTN2 SOS1 | 4.44e-04 | 1221 | 77 | 32 | HP:0001999 |
| HumanPheno | Hematological neoplasm | MYC ASXL1 BRIP1 KIF1B APC2 IKZF1 PTCH1 BRCA1 GLI2 FGFR1 FGFR2 APC FANCM FOXP1 TNFRSF1B SOS1 | 4.72e-04 | 424 | 77 | 16 | HP:0004377 |
| HumanPheno | Megalencephaly | 4.74e-04 | 44 | 77 | 5 | HP:0001355 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | HDAC9 ASXL1 BRIP1 PEX1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 EIF2AK3 WNK3 KNL1 RBBP8 PKDCC APC ARMC9 FANCM ASXL3 ZNF335 VPS13B TCTN2 SOS1 | 4.80e-04 | 1008 | 77 | 28 | HP:0009122 |
| HumanPheno | Abnormality of the ureter | RALGAPA1 ASXL1 BRIP1 APC2 GATA6 SIK1 BPTF SALL1 BRCA1 SCAPER FGFR2 KNL1 FANCM TCTN2 SOS1 | 4.94e-04 | 383 | 77 | 15 | HP:0000069 |
| HumanPheno | Trigonocephaly | 5.27e-04 | 45 | 77 | 5 | HP:0000243 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | BRIP1 GATA6 PEX1 MEF2C BPTF SALL1 BRCA1 SCAPER FGD1 FGFR2 CPLANE1 WNK3 CUL4B RBBP8 PKDCC FANCM ASXL3 VPS13B SOS1 | 5.38e-04 | 564 | 77 | 19 | HP:0009484 |
| HumanPheno | Abnormal palm morphology | ASXL1 PEX1 PTCH1 MEF2C ZNF469 FGD1 FGFR1 FGFR2 CUL4B CAST SLURP1 PKDCC APC ASXL3 FOXP1 DEPDC5 TNFRSF1B VPS13B | 5.76e-04 | 521 | 77 | 18 | HP:0100871 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | HDAC9 ASXL1 BRIP1 PEX1 PTCH1 AHDC1 GATAD2B BPTF HOXB1 BRCA1 GLI2 FGD1 FGFR1 FGFR2 CPLANE1 KNL1 RBBP8 PKDCC APC ARMC9 FANCM ASXL3 ZNF335 VPS13B TCTN2 SOS1 | 5.92e-04 | 915 | 77 | 26 | HP:0009116 |
| HumanPheno | Broad distal phalanx of the hallux | 6.70e-04 | 3 | 77 | 2 | HP:0010077 | |
| HumanPheno | Multiple unerupted teeth | 6.70e-04 | 3 | 77 | 2 | HP:0006283 | |
| HumanPheno | Hypoplasia of the premaxilla | 6.70e-04 | 3 | 77 | 2 | HP:0010650 | |
| HumanPheno | Clinodactyly | BRIP1 GATA6 MEF2C BPTF SALL1 BRCA1 SCAPER FGD1 FGFR1 FGFR2 CPLANE1 WNK3 CUL4B RBBP8 PKDCC FANCM FOXP1 VPS13B SOS1 | 6.70e-04 | 574 | 77 | 19 | HP:0030084 |
| HumanPheno | Oromotor apraxia | 7.50e-04 | 28 | 77 | 4 | HP:0007301 | |
| HumanPheno | Metopic synostosis | 7.50e-04 | 28 | 77 | 4 | HP:0011330 | |
| HumanPheno | Abnormal hair pattern | RALGAPA1 ASXL1 APC2 PEX1 PTCH1 BPTF BRCA1 SCAPER FGD1 FGFR1 FGFR2 KNL1 CUL4B FOS APC ASXL3 ANKRD17 FOXP1 BSCL2 VPS13B SOS1 | 7.63e-04 | 676 | 77 | 21 | HP:0010720 |
| HumanPheno | Abnormal palate morphology | HDAC9 ASXL1 BRIP1 APC2 PEX1 SIK1 PTCH1 GATAD2B HOXB1 ZNF469 BRCA1 GLI2 SCAPER FGD1 FGFR1 FGFR2 HERC1 CPLANE1 EIF2AK3 CUL4B PCLO APC ARMC9 FANCM MTHFR ASXL3 IGHM ANKRD17 VPS13B TCTN2 SOS1 | 7.79e-04 | 1202 | 77 | 31 | HP:0000174 |
| HumanPheno | Aplasia/Hypoplasia of the cerebellum | ASXL1 APC2 MEF2C CDC40 FGFR1 FGFR2 HERC1 CPLANE1 KNL1 CUL4B RBBP8 PCLO ARMC9 ZNF592 MTHFR ASXL3 ZNF335 VPS13B TCTN2 | 7.79e-04 | 581 | 77 | 19 | HP:0007360 |
| HumanPheno | Limb undergrowth | ASXL1 BRIP1 PTCH1 BPTF SALL1 BRCA1 FGD4 FGFR1 FGFR2 CPLANE1 CUL4B PKDCC APC FANCM BSCL2 VPS13B | 7.86e-04 | 444 | 77 | 16 | HP:0009826 |
| HumanPheno | Neonatal hypotonia | GATA6 PEX1 GATAD2B BPTF ZNF469 FGFR1 PCLO GABBR2 MTHFR VPS13B | 8.27e-04 | 202 | 77 | 10 | HP:0001319 |
| HumanPheno | Narrow palate | 8.27e-04 | 202 | 77 | 10 | HP:0000189 | |
| HumanPheno | Abnormal cerebral subcortex morphology | RALGAPA1 ASXL1 APC2 PEX1 SIK1 PTCH1 AHDC1 MEF2C GATAD2B BPTF SALL1 CDC40 GLI2 BRPF1 FGFR1 FGFR2 HERC1 CPLANE1 KNL1 CUL4B RBBP8 PCLO ARMC9 GABBR2 MTHFR ASXL3 ZNF335 DEPDC5 BSCL2 VPS13B TCTN2 | 8.39e-04 | 1207 | 77 | 31 | HP:0010993 |
| HumanPheno | Radial deviation of finger | BRIP1 GATA6 MEF2C BPTF SALL1 BRCA1 SCAPER FGD1 FGFR2 CPLANE1 WNK3 CUL4B RBBP8 FANCM VPS13B SOS1 | 8.66e-04 | 448 | 77 | 16 | HP:0009466 |
| HumanPheno | Finger clinodactyly | BRIP1 GATA6 MEF2C BPTF SALL1 BRCA1 SCAPER FGD1 FGFR2 CPLANE1 CUL4B RBBP8 PKDCC FANCM VPS13B SOS1 | 9.54e-04 | 452 | 77 | 16 | HP:0040019 |
| MousePheno | lethality throughout fetal growth and development | EPOR SP2 ASXL1 ATG13 IKZF1 PTCH1 HEG1 NFATC1 SEC24B FGFR1 FGFR2 TACC3 BRD1 CUL4B APC SIRT1 NCOR2 MTF1 FOXP1 SOS1 | 2.48e-07 | 435 | 167 | 20 | MP:0006208 |
| MousePheno | abnormal craniofacial morphology | ASXL1 AGAP5 KIF1B PTCH1 AHDC1 MEF2C GATAD2B HOXA1 HOXB1 KIRREL3 MAST4 UBR5 GLI2 SEC24B C3orf70 FGD1 FGFR1 FGFR2 TACC3 CPLANE1 KIF27 FOS PKDCC APC FAM227B VPS54 LRRK1 SIRT1 NCOR2 CELSR1 LRIG1 GAS2L2 MTF1 TCTN2 SOS1 | 1.15e-05 | 1372 | 167 | 35 | MP:0000428 |
| MousePheno | craniofacial phenotype | ASXL1 AGAP5 KIF1B PTCH1 AHDC1 MEF2C GATAD2B HOXA1 HOXB1 KIRREL3 MAST4 UBR5 GLI2 SEC24B C3orf70 FGD1 FGFR1 FGFR2 TACC3 CPLANE1 KIF27 FOS PKDCC APC FAM227B VPS54 LRRK1 SIRT1 NCOR2 CELSR1 LRIG1 GAS2L2 MTF1 TCTN2 SOS1 | 1.15e-05 | 1372 | 167 | 35 | MP:0005382 |
| MousePheno | embryonic lethality during organogenesis | MYC EPOR SP2 ATG13 SQLE GATA6 RAD54L2 PTCH1 MEF2C BPTF HEG1 SALL1 BRCA1 UBR5 BRPF1 FGFR1 FGFR2 TACC3 BRD1 CUL4B APC VPS54 SIRT1 ANKRD17 RNF111 SOS1 | 1.49e-05 | 876 | 167 | 26 | MP:0006207 |
| MousePheno | abnormal facial morphology | ASXL1 AGAP5 KIF1B PTCH1 AHDC1 GATAD2B HOXB1 KIRREL3 MAST4 GLI2 C3orf70 FGFR1 FGFR2 TACC3 CPLANE1 KIF27 FOS PKDCC FAM227B VPS54 LRRK1 SIRT1 LRIG1 GAS2L2 TCTN2 SOS1 | 2.86e-05 | 910 | 167 | 26 | MP:0003743 |
| MousePheno | craniorachischisis | 4.14e-05 | 17 | 167 | 4 | MP:0008784 | |
| MousePheno | abnormal head morphology | ASXL1 AGAP5 KIF1B PTCH1 AHDC1 GATAD2B HOXA1 HOXB1 KIRREL3 MAST4 GLI2 SEC24B C3orf70 FGFR1 FGFR2 TACC3 CPLANE1 KIF27 FOS PKDCC APC FAM227B VPS54 LRRK1 SIRT1 LRIG1 GAS2L2 TCTN2 SOS1 | 5.73e-05 | 1120 | 167 | 29 | MP:0000432 |
| MousePheno | abnormal basisphenoid bone morphology | 5.82e-05 | 57 | 167 | 6 | MP:0000106 | |
| MousePheno | abnormal heart ventricle morphology | HDAC9 EPOR ARHGAP24 ATG13 MEF2C HOXA1 HEG1 NFATC1 SEC24B FGFR1 FGFR2 CPLANE1 NR1D2 DUSP7 LAMA4 SIRT1 NCOR2 TNNI3K GAS2L2 ANKRD17 FOXP1 TCTN2 SOS1 | 6.95e-05 | 793 | 167 | 23 | MP:0005294 |
| MousePheno | ventricular septal defect | HOXA1 HEG1 NFATC1 FGFR2 CPLANE1 NR1D2 SIRT1 NCOR2 GAS2L2 FOXP1 TCTN2 SOS1 | 7.05e-05 | 261 | 167 | 12 | MP:0010402 |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | EPOR ASXL1 ATG13 IKZF1 NFATC1 SEC24B FGFR1 TACC3 BRD1 NCOR2 MTF1 FOXP1 | 7.58e-05 | 263 | 167 | 12 | MP:0011099 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | MYC EPOR SP2 SQLE GATA6 RAD54L2 PTCH1 MEF2C BPTF BRCA1 UBR5 BRPF1 FGFR1 FGFR2 TACC3 CUL4B APC VPS54 ANKRD17 RNF111 SOS1 | 9.20e-05 | 700 | 167 | 21 | MP:0011098 |
| MousePheno | abnormal embryonic tissue morphology | MYC SP2 GATA6 RAD54L2 PTCH1 MEF2C HOXA1 BPTF HOXB1 BRCA1 NFATC1 UBR5 GLI2 SEC24B FGFR1 FGFR2 TACC3 BRD1 CUL4B RBBP8 PKDCC APC SIRT1 CELSR1 GAS2L2 ANKRD17 RNF111 TCTN2 | 1.35e-04 | 1116 | 167 | 28 | MP:0002085 |
| MousePheno | premature facial suture closure | 1.42e-04 | 2 | 167 | 2 | MP:0030390 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 1.99e-04 | 208 | 167 | 10 | MP:0011109 | |
| Domain | Znf_FYVE_PHD | 3.68e-06 | 147 | 197 | 10 | IPR011011 | |
| Domain | FYVE | 1.20e-05 | 29 | 197 | 5 | PF01363 | |
| Domain | FYVE | 1.20e-05 | 29 | 197 | 5 | SM00064 | |
| Domain | - | RNF157 BPTF ZFYVE9 BRCA1 FGD4 RNF141 BRPF1 FGD1 BRD1 ZNF598 MARCHF8 PCLO MTMR4 KDM4A FGD6 RNF111 | 2.34e-05 | 449 | 197 | 16 | 3.30.40.10 |
| Domain | Znf_FYVE-rel | 2.69e-05 | 34 | 197 | 5 | IPR017455 | |
| Domain | Znf_RING/FYVE/PHD | RNF157 BPTF ZFYVE9 BRCA1 FGD4 RNF141 BRPF1 FGD1 BRD1 ZNF598 MARCHF8 PCLO MTMR4 KDM4A FGD6 RNF111 | 3.06e-05 | 459 | 197 | 16 | IPR013083 |
| Domain | Znf_FYVE | 4.69e-05 | 38 | 197 | 5 | IPR000306 | |
| Domain | ZF_FYVE | 6.05e-05 | 40 | 197 | 5 | PS50178 | |
| Domain | TNFR_c6 | 7.57e-05 | 22 | 197 | 4 | PF00020 | |
| Domain | APC_r | 1.11e-04 | 2 | 197 | 2 | PF05923 | |
| Domain | SAMP | 1.11e-04 | 2 | 197 | 2 | PF05924 | |
| Domain | APC_dom | 1.11e-04 | 2 | 197 | 2 | IPR026831 | |
| Domain | APC_N | 1.11e-04 | 2 | 197 | 2 | IPR032038 | |
| Domain | APC_basic_dom | 1.11e-04 | 2 | 197 | 2 | IPR009234 | |
| Domain | Apc_fam | 1.11e-04 | 2 | 197 | 2 | IPR026818 | |
| Domain | APC_rpt | 1.11e-04 | 2 | 197 | 2 | IPR009223 | |
| Domain | SAMP | 1.11e-04 | 2 | 197 | 2 | IPR009224 | |
| Domain | APC_basic | 1.11e-04 | 2 | 197 | 2 | PF05956 | |
| Domain | APC_N_CC | 1.11e-04 | 2 | 197 | 2 | PF16689 | |
| Domain | TNFR | 1.50e-04 | 26 | 197 | 4 | SM00208 | |
| Domain | TNFR_NGFR_1 | 2.32e-04 | 29 | 197 | 4 | PS00652 | |
| Domain | TNFR_NGFR_2 | 2.32e-04 | 29 | 197 | 4 | PS50050 | |
| Domain | HARE-HTH | 3.30e-04 | 3 | 197 | 2 | PF05066 | |
| Domain | ASXH | 3.30e-04 | 3 | 197 | 2 | PF13919 | |
| Domain | PHD_3 | 3.30e-04 | 3 | 197 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 3.30e-04 | 3 | 197 | 2 | IPR026905 | |
| Domain | ASXH | 3.30e-04 | 3 | 197 | 2 | IPR028020 | |
| Domain | ASX/ASX-like | 3.30e-04 | 3 | 197 | 2 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 3.30e-04 | 3 | 197 | 2 | IPR007759 | |
| Domain | PROTEIN_KINASE_ATP | SRPK1 SIK1 PASK MAST4 MAP3K9 FGFR1 FGFR2 EIF2AK3 WNK3 PKDCC LRRK1 TESK1 TNNI3K DYRK1B | 3.82e-04 | 459 | 197 | 14 | PS00107 |
| Domain | TNFR/NGFR_Cys_rich_reg | 3.87e-04 | 33 | 197 | 4 | IPR001368 | |
| Domain | MAGE | 4.35e-04 | 34 | 197 | 4 | SM01373 | |
| Domain | ZF_PHD_2 | 5.09e-04 | 95 | 197 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 5.38e-04 | 96 | 197 | 6 | PS01359 | |
| Domain | MAGE | 5.43e-04 | 36 | 197 | 4 | PS50838 | |
| Domain | MHD_dom | 5.43e-04 | 36 | 197 | 4 | IPR002190 | |
| Domain | MAGE | 5.43e-04 | 36 | 197 | 4 | PF01454 | |
| Domain | Kinase-like_dom | SRPK1 SIK1 PASK MAST4 MAP3K9 FGFR1 FGFR2 EIF2AK3 WNK3 PKDCC LRRK1 TESK1 TNNI3K DYRK1B SOS1 | 6.54e-04 | 542 | 197 | 15 | IPR011009 |
| Domain | FGF_rcpt_fam | 6.55e-04 | 4 | 197 | 2 | IPR016248 | |
| Domain | Prot_kinase_dom | SRPK1 SIK1 PASK MAST4 MAP3K9 FGFR1 FGFR2 EIF2AK3 WNK3 PKDCC LRRK1 TESK1 TNNI3K DYRK1B | 7.13e-04 | 489 | 197 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | SRPK1 SIK1 PASK MAST4 MAP3K9 FGFR1 FGFR2 EIF2AK3 WNK3 PKDCC LRRK1 TESK1 TNNI3K DYRK1B | 7.71e-04 | 493 | 197 | 14 | PS50011 |
| Domain | Autophagy-rel_C | 1.08e-03 | 5 | 197 | 2 | IPR015412 | |
| Domain | ATG_C | 1.08e-03 | 5 | 197 | 2 | PF09333 | |
| Domain | ZINC_FINGER_C2H2_2 | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 BRPF1 SCAPER ZNF598 IKZF2 ZNF592 MTF1 ZNF335 SP9 FOXP1 ZNF512 GLIS1 | 1.47e-03 | 775 | 197 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 BRPF1 SCAPER ZNF598 IKZF2 ZNF592 MTF1 ZNF335 SP9 FOXP1 ZNF512 GLIS1 | 1.51e-03 | 777 | 197 | 18 | PS00028 |
| Domain | EPHD | 1.54e-03 | 22 | 197 | 3 | PS51805 | |
| Domain | ZF_FCS | 1.61e-03 | 6 | 197 | 2 | PS51024 | |
| Domain | PET | 1.61e-03 | 6 | 197 | 2 | PF06297 | |
| Domain | PET_domain | 1.61e-03 | 6 | 197 | 2 | IPR010442 | |
| Domain | PET | 1.61e-03 | 6 | 197 | 2 | PS51303 | |
| Domain | Znf_C2H2-like | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 BRPF1 SCAPER ZNF598 IKZF2 ZNF592 MTF1 ZNF335 SP9 FOXP1 ZNF512 GLIS1 | 1.96e-03 | 796 | 197 | 18 | IPR015880 |
| Domain | Znf_C2H2 | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 BRPF1 SCAPER ZNF598 IKZF2 ZNF592 MTF1 ZNF335 SP9 FOXP1 ZNF512 GLIS1 | 2.22e-03 | 805 | 197 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 BRPF1 SCAPER ZNF598 IKZF2 ZNF592 MTF1 ZNF335 SP9 FOXP1 ZNF512 GLIS1 | 2.31e-03 | 808 | 197 | 18 | SM00355 |
| Domain | Pkinase | SRPK1 SIK1 PASK MAST4 MAP3K9 EIF2AK3 WNK3 PKDCC LRRK1 TESK1 DYRK1B | 2.46e-03 | 381 | 197 | 11 | PF00069 |
| Domain | Bromodomain_CS | 2.51e-03 | 26 | 197 | 3 | IPR018359 | |
| Domain | Znf_PHD | 2.77e-03 | 91 | 197 | 5 | IPR001965 | |
| Domain | HECT | 2.81e-03 | 27 | 197 | 3 | PF00632 | |
| Domain | HECTc | 2.81e-03 | 27 | 197 | 3 | SM00119 | |
| Domain | HECT_dom | 2.81e-03 | 27 | 197 | 3 | IPR000569 | |
| Domain | HECT | 2.81e-03 | 27 | 197 | 3 | PS50237 | |
| Domain | PH | 2.84e-03 | 278 | 197 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 2.91e-03 | 279 | 197 | 9 | PS50003 | |
| Domain | Chorein_N | 2.97e-03 | 8 | 197 | 2 | PF12624 | |
| Domain | VPS13_N | 2.97e-03 | 8 | 197 | 2 | IPR026854 | |
| Domain | EPL1 | 2.97e-03 | 8 | 197 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 2.97e-03 | 8 | 197 | 2 | IPR019542 | |
| Domain | PH_domain | 2.98e-03 | 280 | 197 | 9 | IPR001849 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.29e-06 | 143 | 137 | 10 | M39591 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 2.47e-06 | 63 | 137 | 7 | M39623 | |
| Pubmed | MYC PER1 PEX1 ANKHD1 GATAD2B PASK BPTF ZNF469 BRCA1 UBR5 BRPF1 SCAPER BRD1 KNL1 BAHCC1 CUL4B HECTD3 C11orf16 NCKAP5L SIRT1 NCOR2 ZNF592 MTHFR SIPA1L1 ANKRD17 FOXP1 TANC1 ARHGAP33 PHLDB2 EVI5L TCTN2 SOS1 | 8.13e-14 | 1116 | 201 | 32 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BRIP1 KIF1B ITPRID2 GATAD2B PASK BPTF PHC3 BRPF1 TACC3 HOMEZ CUL4B RBBP8 BAG3 CAST SIRT1 NCOR2 PRICKLE3 ZNF592 SIPA1L1 ZNF335 ANKRD17 ELF1 COIL AKAP1 PHLDB2 ZC3HAV1 SOS1 | 9.08e-14 | 774 | 201 | 27 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 ATG13 KIF1B SIK1 ITPRID2 MAST4 SEC24B MAP3K9 BRD1 ZNF598 WNK3 BAG3 APC NCKAP5L SPECC1 TESK1 MTMR4 SIPA1L1 DYRK1B ANKRD17 TANC1 SSH2 AKAP1 FGD6 PHLDB2 AHNAK2 MTSS2 ZC3HAV1 | 1.68e-13 | 861 | 201 | 28 | 36931259 |
| Pubmed | ANKHD1 PHC3 SALL1 UBR5 TACC3 KNL1 HOMEZ SFMBT1 RBBP8 BAG3 ATG2B APC ICE1 ZDBF2 NCOR2 ZNF592 ANKRD17 FOXP1 AKAP1 | 5.85e-12 | 418 | 201 | 19 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A PER1 PTCH1 ANKHD1 TNFRSF21 AHDC1 HEG1 NFATC1 FGFR1 FGFR2 HERC1 GAREM1 BAHCC1 ICE1 LRRK1 TESK1 NCOR2 CELSR1 ZNF592 MTHFR ZNF335 TTLL4 DEPDC5 TANC1 ELL ARHGAP33 EVI5L AHNAK2 | 6.04e-11 | 1105 | 201 | 28 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MYC SETD1A APC2 ITPRID2 RAD54L2 PTCH1 DTNBP1 PHC3 ZNF469 SALL1 CDC40 GLI2 GAREM1 CUL4B TMEM61 MAGEE1 NCOR2 SOS1 | 8.27e-11 | 430 | 201 | 18 | 35044719 |
| Pubmed | MYC SP2 GATA6 GATAD2B BPTF SALL1 NFATC1 BRPF1 SCAPER ZNF598 NR1D2 IKZF2 FOS PRICKLE3 ZNF592 MTF1 ELF1 FOXP1 KDM4A ZNF512 GLIS1 ZC3HAV1 | 2.17e-09 | 808 | 201 | 22 | 20412781 | |
| Pubmed | MYC HDAC9 ITPRID2 MEF2C FBXO30 CPLANE1 GAREM1 FOS BAG3 APC LAMA4 NCKAP5L DYRK1B ANKRD17 ARHGAP33 RNF111 SOS1 | 4.24e-09 | 486 | 201 | 17 | 20936779 | |
| Pubmed | MYC SETD1A SP2 ASXL1 GATA6 RAD54L2 ANKHD1 MEF2C GATAD2B BPTF PHC3 SALL1 BRCA1 GLI2 SEC24B HERC1 HOMEZ SOBP FOS SIRT1 NCOR2 ZNF592 ANKRD17 SP9 ELF1 FOXP1 QSER1 ZNF512 ZC3HAV1 | 4.39e-09 | 1429 | 201 | 29 | 35140242 | |
| Pubmed | MYC SP2 KIF1B GATA6 IKZF1 MEF2C HOXA1 ZIC4 BRCA1 GLI2 BRPF1 TACC3 NR1D2 IKZF2 FOS PRICKLE3 MTF1 ELF1 KDM4A RNF111 | 6.75e-09 | 709 | 201 | 20 | 22988430 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MYC HDAC9 SP2 BRIP1 PER1 GATA6 MEF2C HOXA1 HOXB1 BRCA1 BRPF1 BRD1 IKZF2 FOS APC SIRT1 NCOR2 PRICKLE3 ZNF592 MTF1 FOXP1 ELL | 9.53e-09 | 877 | 201 | 22 | 20211142 |
| Pubmed | 7.44e-08 | 8 | 201 | 4 | 11959865 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | AGAP5 AHDC1 BPTF SMYD4 GLI2 FGFR1 SPATS2 BRD1 NCOR2 SIPA1L1 TTLL4 ELF1 FOXP1 KDM4A TANC1 SOS1 | 1.09e-07 | 536 | 201 | 16 | 15840001 |
| Pubmed | AGAP5 AHDC1 BPTF SMYD4 GLI2 FGFR1 SPATS2 BRD1 NCOR2 SIPA1L1 TTLL4 ELF1 FOXP1 KDM4A TANC1 SOS1 | 1.14e-07 | 538 | 201 | 16 | 10512203 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 TSHZ2 ATG13 KIF1B RTN3 AHDC1 BPTF NFATC1 GLI2 SPATS2 SOBP CAST VPS54 SLC1A1 NCOR2 ANKRD17 FOXP1 TANC1 BSCL2 GREB1 QSER1 ZNF512 ICA1L GLIS1 VPS13B EVI5L ZC3HAV1 | 1.55e-07 | 1489 | 201 | 27 | 28611215 |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A RAD54L2 AHDC1 BPTF SALL1 HOMEZ BAHCC1 SOBP SIRT1 NCOR2 ASXL3 FOXP1 QSER1 | 1.55e-07 | 351 | 201 | 13 | 38297188 |
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 19452558 | ||
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 18285836 | ||
| Pubmed | 2.21e-07 | 10 | 201 | 4 | 10512189 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYC SP2 TSHZ2 GATA6 IKZF1 MEF2C HOXA1 HOXB1 SALL1 NFATC1 GLI2 NR1D2 HOMEZ FOS MTF1 ZNF335 SP9 ELF1 FOXP1 GLIS1 | 3.71e-07 | 908 | 201 | 20 | 19274049 |
| Pubmed | RALGAPA1 SETD1A AGAP5 ANKHD1 PASK MAST4 ARHGAP20 HOMEZ ICE1 LRRK1 ZNF592 TTLL4 ANKRD17 DEPDC5 KDM4A | 5.26e-07 | 529 | 201 | 15 | 14621295 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MYC ASXL1 PER1 ANKHD1 MEF2C GATAD2B BPTF SALL1 NFATC1 UBR5 ZNF598 EIF2AK3 SFMBT1 KIF27 FOS NCOR2 ANKRD17 FOXP1 QSER1 | 6.70e-07 | 857 | 201 | 19 | 25609649 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | MYC PER1 RTN3 SIK1 DTNBP1 PASK HROB UBR5 SEC24B TBC1D12 SPATS2 GAREM1 GRWD1 DUSP7 NCKAP5L PRICKLE3 TTLL4 SSH2 COIL EVI5L ZC3HAV1 | 7.40e-07 | 1038 | 201 | 21 | 26673895 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SP2 GATA6 MEF2C HOXA1 ZIC4 HOXB1 NFATC1 GLI2 NR1D2 FOS MTF1 SP9 ELF1 FOXP1 GLIS1 | 7.47e-07 | 544 | 201 | 15 | 28473536 |
| Pubmed | UBR5 SEC24B PRR14L EIF2AK3 CUL4B BAG3 ATG2B CAST ZDBF2 NUP35 TANC1 AKAP1 VPS13B AHNAK2 ZC3HAV1 | 1.27e-06 | 568 | 201 | 15 | 37774976 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | MYC SETD1A ASXL1 AHDC1 GATAD2B FBXO30 BPTF PHC3 KNL1 SFMBT1 SLURP1 SPECC1 DYRK1B CBX8 | 1.31e-06 | 495 | 201 | 14 | 27705803 |
| Pubmed | RALGAPA1 PEX1 RTN3 ZFYVE9 SEC24B KXD1 EIF2AK3 ATG2B SLC1A1 NUP35 LRIG1 AKAP1 VPS13B ZC3HAV1 | 1.62e-06 | 504 | 201 | 14 | 34432599 | |
| Pubmed | 1.89e-06 | 5 | 201 | 3 | 27141965 | ||
| Pubmed | Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. | 1.89e-06 | 5 | 201 | 3 | 17525342 | |
| Pubmed | 1.89e-06 | 5 | 201 | 3 | 24413172 | ||
| Pubmed | 1.89e-06 | 5 | 201 | 3 | 15546868 | ||
| Pubmed | 1.89e-06 | 5 | 201 | 3 | 30257991 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF1B RTN3 ITPRID2 RAD54L2 SALL1 NFATC1 UBR5 KNL1 RBBP8 APC ZDBF2 NCKAP5L SIRT1 NCOR2 TANC1 | 1.95e-06 | 588 | 201 | 15 | 38580884 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ATG13 KIF1B HROB MAST4 UBR5 BRPF1 SEC24B CPLANE1 ZNF598 CUL4B CAST APC NCKAP5L SIPA1L1 TANC1 ELL CBX8 ZC3HAV1 | 2.67e-06 | 853 | 201 | 18 | 28718761 |
| Pubmed | 2.80e-06 | 257 | 201 | 10 | 30945288 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BRIP1 GATAD2B BPTF PHC3 BRCA1 BRPF1 BRD1 HOMEZ SIRT1 ZNF592 ELF1 KDM4A QSER1 ZNF512 CBX8 | 2.93e-06 | 608 | 201 | 15 | 36089195 |
| Pubmed | ARHGAP24 APC2 GATAD2B UBR5 KCTD16 SPATS2 TACC3 WNK3 ANK2 APC GABBR2 NCOR2 SIPA1L1 ANKRD17 SSH2 QSER1 FRMPD3 PHLDB2 MTSS2 | 3.68e-06 | 963 | 201 | 19 | 28671696 | |
| Pubmed | Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. | 3.76e-06 | 6 | 201 | 3 | 17525340 | |
| Pubmed | PALB2 is an integral component of the BRCA complex required for homologous recombination repair. | 3.76e-06 | 6 | 201 | 3 | 19369211 | |
| Pubmed | FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response. | 3.76e-06 | 6 | 201 | 3 | 22792074 | |
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 3.92e-06 | 19 | 201 | 4 | 14578343 | |
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | RTN3 IKZF1 DTNBP1 ANKHD1 HROB KXD1 CUL4B IKZF2 RBBP8 FOS BSCL2 COIL EVI5L | 5.40e-06 | 483 | 201 | 13 | 27107014 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 5.51e-06 | 218 | 201 | 9 | 33378226 | |
| Pubmed | Temporomandibular joint formation requires two distinct hedgehog-dependent steps. | 6.00e-06 | 21 | 201 | 4 | 19815519 | |
| Pubmed | RALGAPA1 BRIP1 GATAD2B PRR14L KNL1 CUL4B SLC43A1 APC ICE1 ZDBF2 NCKAP5L MTMR4 TTLL4 TANC1 QSER1 AKAP1 | 6.42e-06 | 733 | 201 | 16 | 34672954 | |
| Pubmed | SRPK1 ITPRID2 ANKHD1 AHDC1 GATAD2B PHC3 BRCA1 FGD4 SEC24B SPATS2 ZNF598 GRWD1 APC ICE1 SPECC1 NUP35 CELSR1 ZNF592 SIPA1L1 ANKRD17 TANC1 AKAP1 CBX8 ZC3HAV1 | 6.65e-06 | 1497 | 201 | 24 | 31527615 | |
| Pubmed | 7.30e-06 | 22 | 201 | 4 | 28027321 | ||
| Pubmed | HuR controls lung branching morphogenesis and mesenchymal FGF networks. | 8.80e-06 | 23 | 201 | 4 | 21515253 | |
| Pubmed | 1.04e-05 | 8 | 201 | 3 | 18563556 | ||
| Pubmed | Abnormal level of CUL4B-mediated histone H2A ubiquitination causes disruptive HOX gene expression. | 1.04e-05 | 8 | 201 | 3 | 30992047 | |
| Pubmed | Vegf regulates embryonic erythroid development through Gata1 modulation. | 1.05e-05 | 24 | 201 | 4 | 20554972 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BRIP1 GATAD2B BPTF PHC3 SALL1 BRCA1 KNL1 CUL4B CAST ICE1 ZDBF2 FANCM NCOR2 QSER1 COIL ZNF512 ELL CBX8 | 1.22e-05 | 954 | 201 | 18 | 36373674 |
| Pubmed | FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. | 1.25e-05 | 25 | 201 | 4 | 18625063 | |
| Pubmed | Diverse Fgfr1 signaling pathways and endocytic trafficking regulate mesoderm development. | 1.25e-05 | 25 | 201 | 4 | 38834239 | |
| Pubmed | 1.25e-05 | 25 | 201 | 4 | 23271346 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.27e-05 | 184 | 201 | 8 | 32908313 | |
| Pubmed | 1.35e-05 | 89 | 201 | 6 | 18950845 | ||
| Pubmed | Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos. | 1.47e-05 | 26 | 201 | 4 | 37228654 | |
| Pubmed | 1.51e-05 | 136 | 201 | 7 | 25429064 | ||
| Pubmed | Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. | 1.56e-05 | 9 | 201 | 3 | 28398198 | |
| Pubmed | 1.56e-05 | 9 | 201 | 3 | 22142223 | ||
| Pubmed | 1.56e-05 | 9 | 201 | 3 | 26269593 | ||
| Pubmed | 1.56e-05 | 9 | 201 | 3 | 27802276 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | SP2 PEX1 GATAD2B NFATC1 SPATS2 SPECC1 NCOR2 ANKRD17 PHLDB2 ZC3HAV1 | 1.95e-05 | 321 | 201 | 10 | 32098917 |
| Pubmed | Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme. | 2.21e-05 | 10 | 201 | 3 | 16442091 | |
| Pubmed | 2.21e-05 | 10 | 201 | 3 | 25252691 | ||
| Pubmed | 2.21e-05 | 10 | 201 | 3 | 16284117 | ||
| Pubmed | 2.21e-05 | 10 | 201 | 3 | 26290144 | ||
| Pubmed | 2.21e-05 | 10 | 201 | 3 | 28552559 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SP2 GATAD2B PHC3 SALL1 BAHCC1 PCLO APC NCKAP5L NCOR2 DYRK1B FOXP1 | 2.27e-05 | 398 | 201 | 11 | 35016035 |
| Pubmed | 2.78e-05 | 101 | 201 | 6 | 10997877 | ||
| Pubmed | 2.94e-05 | 102 | 201 | 6 | 9734811 | ||
| Pubmed | 3.01e-05 | 31 | 201 | 4 | 19690177 | ||
| Pubmed | 3.03e-05 | 11 | 201 | 3 | 19584272 | ||
| Pubmed | 3.03e-05 | 11 | 201 | 3 | 21451043 | ||
| Pubmed | Fgf3 and Fgf10 are required for mouse otic placode induction. | 3.03e-05 | 11 | 201 | 3 | 12810586 | |
| Pubmed | 3.03e-05 | 11 | 201 | 3 | 16396903 | ||
| Pubmed | 3.17e-05 | 209 | 201 | 8 | 36779422 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23712259 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21538817 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 16890163 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34882194 | ||
| Pubmed | MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. | 3.32e-05 | 2 | 201 | 2 | 11922389 | |
| Pubmed | A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer. | 3.32e-05 | 2 | 201 | 2 | 25323003 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 15863034 | ||
| Pubmed | Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. | 3.32e-05 | 2 | 201 | 2 | 28187268 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23474493 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 1652059 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 20308431 | ||
| Pubmed | Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine. | 3.32e-05 | 2 | 201 | 2 | 20140021 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 37579831 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 25807524 | ||
| Pubmed | Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. | 3.32e-05 | 2 | 201 | 2 | 30914635 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 22791819 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 20825051 | ||
| Pubmed | Cloning and characterization of a histone deacetylase, HDAC9. | 3.32e-05 | 2 | 201 | 2 | 11535832 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28911102 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 25171497 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors 1 and 2 in mouse palate development. | 3.32e-05 | 2 | 201 | 2 | 11391199 | |
| Pubmed | Characterization of a carboxy-terminal BRCA1 interacting protein. | 3.32e-05 | 2 | 201 | 2 | 9811458 | |
| Interaction | FHL2 interactions | MYC SETD1A SP2 IKZF1 PTCH1 GATAD2B PHC3 ZFYVE9 BRCA1 WNK3 KNL1 BAHCC1 APC SIRT1 NCOR2 ANKRD17 ELF1 FOXP1 QSER1 RNF111 | 2.44e-09 | 396 | 198 | 20 | int:FHL2 |
| Interaction | HDAC1 interactions | MYC HDAC9 PADI4 IKZF1 ANKHD1 GATAD2B RNF157 BPTF SALL1 BRCA1 NFATC1 UBR5 GLI2 TACC3 NR1D2 KNL1 BAHCC1 CUL4B SFMBT1 IKZF2 RBBP8 BAG3 ATG2B APC ZDBF2 SIRT1 NCOR2 ZNF592 ANKRD17 KDM4A COIL AKAP1 ELL | 1.10e-08 | 1108 | 198 | 33 | int:HDAC1 |
| Interaction | CTBP1 interactions | MYC HDAC9 IKZF1 PHC3 BRCA1 NFATC1 CUL4B IKZF2 RBBP8 SOBP PCLO BAG3 APC NCKAP5L NCOR2 DYRK1B FOXP1 DEPDC5 RNF111 | 2.14e-08 | 406 | 198 | 19 | int:CTBP1 |
| Interaction | FOXP1 interactions | MYC PER1 IKZF1 GATAD2B SALL1 HERC1 BRD1 CUL4B KIF27 LRRK1 NCOR2 FOXP1 QSER1 TNFRSF1B ZC3HAV1 | 3.80e-08 | 256 | 198 | 15 | int:FOXP1 |
| Interaction | NUP43 interactions | SETD1A BRIP1 ITPRID2 RAD54L2 AHDC1 BPTF PHC3 BRCA1 UBR5 NR1D2 KNL1 RBBP8 APC ICE1 ZDBF2 NCOR2 ZNF592 ELF1 COIL ZNF512 CBX8 AHNAK2 | 2.44e-07 | 625 | 198 | 22 | int:NUP43 |
| Interaction | PHF21A interactions | MYC ANKHD1 SALL1 UBR5 TACC3 KNL1 CUL4B SFMBT1 RBBP8 ATG2B APC ICE1 ZDBF2 NCKAP5L ZNF592 AKAP1 | 3.04e-07 | 343 | 198 | 16 | int:PHF21A |
| Interaction | YWHAZ interactions | MYC RALGAPA1 HDAC9 ASXL1 ATG13 KIF1B SIK1 ITPRID2 MEF2C MAST4 BRCA1 KCTD16 MAP3K9 PRR14L BRD1 ZNF598 GAREM1 HOMEZ BAG3 APC NCKAP5L SPECC1 MTMR4 PRICKLE3 ASXL3 SIPA1L1 ANKRD17 DEPDC5 TANC1 SSH2 FGD6 PHLDB2 MTSS2 | 6.38e-07 | 1319 | 198 | 33 | int:YWHAZ |
| Interaction | YWHAB interactions | MYC RALGAPA1 ATG13 KIF1B RTN3 SIK1 ITPRID2 MAST4 MAP3K9 FGFR1 FGFR2 BRD1 HOMEZ BAG3 APC NCKAP5L SPECC1 TESK1 MTMR4 PRICKLE3 SIPA1L1 ANKRD17 TANC1 SSH2 FGD6 PHLDB2 AHNAK2 MTSS2 | 7.49e-07 | 1014 | 198 | 28 | int:YWHAB |
| Interaction | FEV interactions | SETD1A SP2 GATA6 RAD54L2 PHC3 SALL1 HOMEZ NCOR2 ELF1 FOXP1 QSER1 ZNF512 | 8.28e-07 | 203 | 198 | 12 | int:FEV |
| Interaction | TOP3B interactions | SETD1A KIF1B PER1 PTCH1 ANKHD1 TNFRSF21 AHDC1 HEG1 NFATC1 SEC24B FGFR1 FGFR2 HERC1 ZNF598 GAREM1 BAHCC1 GRWD1 ICE1 LRRK1 TESK1 NCOR2 CELSR1 ZNF592 MTHFR ZNF335 TTLL4 ANKRD17 DEPDC5 KDM4A TANC1 ELL ARHGAP33 EVI5L AHNAK2 ZC3HAV1 | 8.79e-07 | 1470 | 198 | 35 | int:TOP3B |
| Interaction | NPAS1 interactions | PER1 PEX1 ANKHD1 PASK SMYD4 PHC3 HERC1 KNL1 BAG3 ATG2B NCOR2 QSER1 AKAP1 | 9.74e-07 | 245 | 198 | 13 | int:NPAS1 |
| Interaction | YWHAH interactions | RALGAPA1 ATG13 KIF1B SIK1 ITPRID2 MAST4 SEC24B MAP3K9 HERC1 BRD1 WNK3 HOMEZ BAG3 APC NCKAP5L SPECC1 TESK1 MTMR4 PRICKLE3 SIPA1L1 ANKRD17 TANC1 SSH2 AKAP1 FGD6 PHLDB2 AHNAK2 MTSS2 ZC3HAV1 | 1.23e-06 | 1102 | 198 | 29 | int:YWHAH |
| Interaction | YWHAG interactions | MYC KIAA0408 RALGAPA1 ATG13 KIF1B RTN3 SRPK1 SIK1 ITPRID2 MAST4 SEC24B MAP3K9 BRD1 GAREM1 HOMEZ BAG3 APC NCKAP5L SPECC1 TESK1 MTMR4 PRICKLE3 SIPA1L1 ANKRD17 TANC1 SSH2 FGD6 PHLDB2 AHNAK2 MTSS2 ZC3HAV1 | 1.70e-06 | 1248 | 198 | 31 | int:YWHAG |
| Interaction | KDM1A interactions | MYC KIAA0408 IKZF1 ANKHD1 HOXA1 KRT39 PHC3 BRCA1 UBR5 TACC3 ZNF598 KNL1 HOMEZ SFMBT1 RBBP8 BAG3 ATG2B APC ICE1 ZDBF2 NCOR2 ZNF592 ANKRD17 FOXP1 COIL AKAP1 | 1.92e-06 | 941 | 198 | 26 | int:KDM1A |
| Interaction | RCOR1 interactions | MYC ANKHD1 SALL1 UBR5 KNL1 CUL4B SFMBT1 RBBP8 BAG3 ATG2B APC ICE1 ZDBF2 NCKAP5L NCOR2 ZNF592 ANKRD17 AKAP1 | 1.98e-06 | 494 | 198 | 18 | int:RCOR1 |
| Interaction | FOXK2 interactions | MYC ASXL1 PER1 IKZF1 BPTF NFATC1 EIF2AK3 NUP35 NCOR2 MTMR4 ASXL3 ELF1 | 2.44e-06 | 225 | 198 | 12 | int:FOXK2 |
| Interaction | BAG2 interactions | MYC SETD1A ASXL1 PEX1 ANKHD1 BPTF PHC3 PRR14L FGFR1 TACC3 BRD1 ZNF598 WNK3 KNL1 BAG3 LRRK1 GREB1 QSER1 AKAP1 VPS13B | 3.53e-06 | 622 | 198 | 20 | int:BAG2 |
| Interaction | SFN interactions | MYC KIAA0408 RALGAPA1 HDAC9 SETD1A ATG13 KIF1B ITPRID2 MAST4 APC NCKAP5L SPECC1 MTMR4 SIPA1L1 ANKRD17 TANC1 SSH2 FGD6 PHLDB2 AHNAK2 MTSS2 | 4.89e-06 | 692 | 198 | 21 | int:SFN |
| Interaction | ZBBX interactions | 1.20e-05 | 31 | 198 | 5 | int:ZBBX | |
| Interaction | MAPRE3 interactions | KIF1B APC2 IKZF1 HROB MAST4 ZNF598 APC NCKAP5L SPECC1 GAS2L2 TANC1 | 1.80e-05 | 230 | 198 | 11 | int:MAPRE3 |
| Interaction | HMGN5 interactions | 2.21e-05 | 154 | 198 | 9 | int:HMGN5 | |
| Interaction | ZYX interactions | FGFR1 TACC3 ZNF598 WNK3 CUL4B ANK2 BAG3 APC SIRT1 SIPA1L1 TANC1 SSH2 AHNAK2 | 2.38e-05 | 329 | 198 | 13 | int:ZYX |
| Interaction | FOXK1 interactions | ASXL1 ARHGAP24 IKZF1 NFATC1 EIF2AK3 NUP35 MTMR4 ASXL3 DYRK1B ELF1 COIL | 2.47e-05 | 238 | 198 | 11 | int:FOXK1 |
| Interaction | NFE2L2 interactions | 2.84e-05 | 159 | 198 | 9 | int:NFE2L2 | |
| Interaction | GATAD2B interactions | MYC ASXL1 IKZF1 GATAD2B BPTF SALL1 BRCA1 NFATC1 ZNF598 MAGEE1 FOXP1 | 3.22e-05 | 245 | 198 | 11 | int:GATAD2B |
| Interaction | USP7 interactions | MYC KIAA0408 PADI4 SRPK1 IKZF1 TNFRSF21 SALL1 BRCA1 GLI2 BRPF1 NXF3 HERC1 WNK3 CUL4B GRWD1 APC ZDBF2 TEX15 MAGEE1 GABBR2 SIRT1 FETUB ZNF335 COIL AKAP1 VPS13B CBX8 PHLDB2 ZC3HAV1 | 3.50e-05 | 1313 | 198 | 29 | int:USP7 |
| Interaction | TRIM24 interactions | MYC DTNBP1 ANKHD1 KRT39 BRCA1 RNF141 BRPF1 KXD1 FOS NUP35 ANKRD17 ELF1 TANC1 ZC3HAV1 | 4.16e-05 | 398 | 198 | 14 | int:TRIM24 |
| Interaction | YY1 interactions | MYC SETD1A ASXL1 BPTF PHC3 BRCA1 BRD1 FOS TESK1 ZNF592 ELF1 FOXP1 COIL ZNF512 MTSS2 | 4.52e-05 | 454 | 198 | 15 | int:YY1 |
| Interaction | SNRNP40 interactions | MYC BRIP1 ATG13 SRPK1 AHDC1 PHC3 BRCA1 CDC40 UBR5 KNL1 CUL4B RBBP8 ZDBF2 NCOR2 ELF1 COIL ZNF512 CBX8 | 6.06e-05 | 637 | 198 | 18 | int:SNRNP40 |
| Interaction | MATK interactions | 6.19e-05 | 43 | 198 | 5 | int:MATK | |
| Interaction | C2CD4B interactions | 6.92e-05 | 44 | 198 | 5 | int:C2CD4B | |
| Interaction | UBE2I interactions | MYC TSHZ2 KIF1B IKZF1 RAD54L2 MEF2C SALL1 BRCA1 NFATC1 GLI2 NR1D2 RBBP8 FOS FANCM SIRT1 NUP35 NCOR2 RNF111 | 8.47e-05 | 654 | 198 | 18 | int:UBE2I |
| Interaction | TLE3 interactions | MYC BRIP1 RAD54L2 AHDC1 PHC3 SALL1 UBR5 GLI2 KNL1 CUL4B RBBP8 NUP35 NCOR2 | 9.33e-05 | 376 | 198 | 13 | int:TLE3 |
| Interaction | RNF169 interactions | 1.03e-04 | 76 | 198 | 6 | int:RNF169 | |
| Interaction | YWHAQ interactions | MYC RALGAPA1 KIF1B SIK1 ITPRID2 MAST4 BRCA1 NFATC1 MAP3K9 BRD1 GAREM1 HOMEZ BAG3 APC NCKAP5L SPECC1 MTMR4 IGHM SIPA1L1 ANKRD17 TANC1 SSH2 FGD6 PHLDB2 MTSS2 | 1.05e-04 | 1118 | 198 | 25 | int:YWHAQ |
| Interaction | YWHAE interactions | MYC RALGAPA1 HDAC9 KIF1B SIK1 ITPRID2 MAST4 BRCA1 MAP3K9 BRD1 ZNF598 GAREM1 BAG3 APC NCKAP5L SPECC1 NCOR2 MTMR4 PRICKLE3 SIPA1L1 ANKRD17 DEPDC5 TANC1 SSH2 FGD6 ARHGAP33 PHLDB2 | 1.05e-04 | 1256 | 198 | 27 | int:YWHAE |
| Interaction | PHF12 interactions | 1.08e-04 | 110 | 198 | 7 | int:PHF12 | |
| Interaction | ZNF207 interactions | 1.14e-04 | 111 | 198 | 7 | int:ZNF207 | |
| Interaction | HDAC2 interactions | MYC HDAC9 PADI4 IKZF1 GATAD2B BPTF SALL1 BRCA1 NFATC1 SPATS2 ZNF598 CUL4B SFMBT1 IKZF2 RBBP8 BAG3 SIRT1 NCOR2 ANKRD17 AHNAK2 ZC3HAV1 | 1.28e-04 | 865 | 198 | 21 | int:HDAC2 |
| Interaction | PFN1 interactions | MYC ARHGAP24 RTN3 SRPK1 ANKHD1 BRCA1 SEC24B ANK2 PCLO BAG3 APC TANC1 ELL AHNAK2 MTSS2 | 1.61e-04 | 509 | 198 | 15 | int:PFN1 |
| Interaction | GABARAPL1 interactions | 1.65e-04 | 157 | 198 | 8 | int:GABARAPL1 | |
| Interaction | MST1R interactions | 1.67e-04 | 200 | 198 | 9 | int:MST1R | |
| Interaction | WHAMMP3 interactions | 1.76e-04 | 119 | 198 | 7 | int:WHAMMP3 | |
| Interaction | SULF2 interactions | 1.76e-04 | 119 | 198 | 7 | int:SULF2 | |
| Interaction | RAB4A interactions | RALGAPA1 KIF1B ZFYVE9 SEC24B TBC1D12 FGFR1 BAG3 ATG2B VPS54 LRIG1 AKAP1 VPS13B AHNAK2 ZC3HAV1 | 1.79e-04 | 457 | 198 | 14 | int:RAB4A |
| Interaction | USF1 interactions | 1.91e-04 | 85 | 198 | 6 | int:USF1 | |
| Interaction | KLB interactions | 1.93e-04 | 12 | 198 | 3 | int:KLB | |
| Interaction | DPY30 interactions | 1.93e-04 | 204 | 198 | 9 | int:DPY30 | |
| Interaction | ZBTB21 interactions | 1.96e-04 | 161 | 198 | 8 | int:ZBTB21 | |
| Interaction | DUSP5 interactions | 2.03e-04 | 55 | 198 | 5 | int:DUSP5 | |
| Interaction | GSC interactions | 2.17e-04 | 87 | 198 | 6 | int:GSC | |
| Interaction | SALL2 interactions | 2.31e-04 | 88 | 198 | 6 | int:SALL2 | |
| Interaction | NFIC interactions | 2.40e-04 | 210 | 198 | 9 | int:NFIC | |
| Interaction | FBXW11 interactions | PER1 PEX1 UBR5 GLI2 KNL1 CUL4B BAG3 APC FANCM NCKAP5L PRICKLE3 SIPA1L1 TANC1 MTSS2 | 2.55e-04 | 473 | 198 | 14 | int:FBXW11 |
| Interaction | PLAU interactions | 2.61e-04 | 58 | 198 | 5 | int:PLAU | |
| Interaction | CSNK1A1L interactions | 2.61e-04 | 58 | 198 | 5 | int:CSNK1A1L | |
| Interaction | ICE1 interactions | 2.83e-04 | 59 | 198 | 5 | int:ICE1 | |
| Interaction | FGF11 interactions | 2.84e-04 | 170 | 198 | 8 | int:FGF11 | |
| Interaction | CREBBP interactions | MYC SETD1A BRIP1 HOXB1 BRCA1 NFATC1 FGFR1 FOS APC TXNDC11 NUP35 NCOR2 ZNF592 MTF1 DYRK1B RNF111 | 2.95e-04 | 599 | 198 | 16 | int:CREBBP |
| Interaction | EGR2 interactions | 2.96e-04 | 171 | 198 | 8 | int:EGR2 | |
| Interaction | GATAD1 interactions | 3.18e-04 | 131 | 198 | 7 | int:GATAD1 | |
| Interaction | SMG7 interactions | SALL1 BRCA1 ZDBF2 SIRT1 NUP35 NCOR2 MTMR4 ANKRD17 COIL AKAP1 ZC3HAV1 | 3.31e-04 | 319 | 198 | 11 | int:SMG7 |
| Interaction | SOX2 interactions | SP2 SRPK1 ITPRID2 ANKHD1 AHDC1 MEF2C GATAD2B BPTF PHC3 SALL1 UBR5 MAGEC1 SPATS2 CPLANE1 KNL1 HOMEZ CUL4B BAG3 ZDBF2 LBP NCOR2 CELSR1 IGHM SIPA1L1 ANKRD17 FOXP1 QSER1 ZNF512 | 3.34e-04 | 1422 | 198 | 28 | int:SOX2 |
| Interaction | NUP93 interactions | 3.42e-04 | 269 | 198 | 10 | int:NUP93 | |
| Cytoband | 1p32.3 | 1.53e-04 | 61 | 201 | 4 | 1p32.3 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.88e-06 | 31 | 141 | 5 | 81 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 7.23e-05 | 29 | 141 | 4 | 782 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.82e-05 | 181 | 141 | 8 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.15e-04 | 206 | 141 | 8 | 682 | |
| GeneFamily | MAGE family | 2.60e-04 | 40 | 141 | 4 | 1136 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 3.59e-04 | 4 | 141 | 2 | 1335 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 3.59e-04 | 4 | 141 | 2 | 1184 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.80e-04 | 20 | 141 | 3 | 548 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | SP2 TSHZ2 IKZF1 ZIC4 ZNF469 SALL1 GLI2 SCAPER ZNF598 IKZF2 ZNF592 ZNF335 SP9 ZNF512 GLIS1 | 4.92e-04 | 718 | 141 | 15 | 28 |
| GeneFamily | CD molecules|Mucins | 5.57e-04 | 21 | 141 | 3 | 648 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.95e-04 | 5 | 141 | 2 | 1336 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 6.18e-04 | 50 | 141 | 4 | 721 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.76e-03 | 66 | 141 | 4 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.10e-03 | 9 | 141 | 2 | 755 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.56e-03 | 43 | 141 | 3 | 409 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.93e-03 | 15 | 141 | 2 | 529 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.93e-03 | 15 | 141 | 2 | 82 | |
| GeneFamily | PDZ domain containing | 6.81e-03 | 152 | 141 | 5 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.62e-03 | 161 | 141 | 5 | 593 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 ASXL1 BPTF BRCA1 PRR14L HERC1 ATG2B SIPA1L1 TTLL4 DYRK1B DEPDC5 SOS1 | 1.60e-08 | 180 | 201 | 12 | M8239 |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_EARLY | MYC MAST4 RBBP8 FOS SLC1A1 NCOR2 CELSR1 LRIG1 ELF1 GREB1 AKAP1 | 4.50e-07 | 200 | 201 | 11 | M5906 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SP2 PER1 SIK1 SEC24B MAP3K9 FGFR1 BRD1 EIF2AK3 NR1D2 GAREM1 FOS BAG3 SIRT1 MTF1 ELF1 KDM4A FGD6 ELL AHNAK2 ZC3HAV1 SOS1 | 1.57e-06 | 822 | 201 | 21 | M6782 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | MYC ASXL1 AHDC1 BPTF HEG1 MAST4 UBR5 FGFR2 DUSP7 ICE1 ELF1 VPS13B | 3.85e-06 | 300 | 201 | 12 | M8702 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 ATG13 KIF1B PEX1 SIK1 ANKHD1 TNFRSF21 KIRREL3 BRCA1 FGFR2 NR1D2 IKZF2 FOS DUSP7 DUSP15 LBP SPECC1 SLC1A1 MTMR4 LRIG1 ELF1 FOXP1 PHLDB2 TCTN2 | 4.36e-06 | 1102 | 201 | 24 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | HDAC9 ATG13 KIF1B PEX1 SIK1 ANKHD1 TNFRSF21 KIRREL3 BRCA1 FGFR2 NR1D2 IKZF2 FOS DUSP7 DUSP15 LBP SPECC1 SLC1A1 MTMR4 LRIG1 ELF1 FOXP1 PHLDB2 TCTN2 | 6.08e-06 | 1124 | 201 | 24 | MM1070 |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 1.23e-05 | 100 | 201 | 7 | M5775 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ARHGAP24 LHFPL4 TSHZ2 APC2 PEX1 AHDC1 RNF157 MAST4 LRFN5 MAP3K9 HERC1 BRD1 WNK3 ANK2 SOBP PCLO APC GABBR2 ASXL3 SSH2 FRMPD3 ICA1L AHNAK2 | 1.47e-05 | 1106 | 201 | 23 | M39071 |
| Coexpression | TURJANSKI_MAPK7_TARGETS | 1.52e-05 | 7 | 201 | 3 | M11218 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | ASXL1 TAGAP ARHGAP20 CPLANE1 VPS54 GAS2L2 MTHFR ASXL3 VPS13B | 2.56e-05 | 200 | 201 | 9 | M7776 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | BRIP1 RAD54L2 PASK HROB BRCA1 FGFR1 TACC3 KNL1 SFMBT1 ANK2 PCLO SPECC1 GREB1 FGD6 ICA1L | 3.49e-05 | 567 | 201 | 15 | M45692 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP | 6.21e-05 | 174 | 201 | 8 | M6817 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 8.19e-05 | 181 | 201 | 8 | M8662 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 8.19e-05 | 181 | 201 | 8 | M6857 | |
| Coexpression | E2F1_UP.V1_DN | 1.03e-04 | 187 | 201 | 8 | M2630 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP | 1.42e-04 | 196 | 201 | 8 | M4999 | |
| Coexpression | GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP | 1.47e-04 | 197 | 201 | 8 | M3480 | |
| Coexpression | GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 1.47e-04 | 197 | 201 | 8 | M4237 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.58e-04 | 199 | 201 | 8 | M313 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP | 1.58e-04 | 199 | 201 | 8 | M8255 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP | 1.58e-04 | 199 | 201 | 8 | M6183 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_UP | 1.58e-04 | 199 | 201 | 8 | M5432 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | ARHGAP24 SLC22A17 RNF157 SPATS2 ARHGAP20 SLC43A1 PKDCC GREB1 | 1.58e-04 | 199 | 201 | 8 | M9178 |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 1.62e-04 | 105 | 201 | 6 | M12602 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_DN | 1.63e-04 | 200 | 201 | 8 | M4863 | |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | 1.63e-04 | 200 | 201 | 8 | M3419 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP | 1.63e-04 | 200 | 201 | 8 | M5074 | |
| Coexpression | LU_AGING_BRAIN_DN | 1.85e-04 | 153 | 201 | 7 | M9112 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | MYC GATA6 SIK1 GLI2 NXF3 ARHGAP20 WNK3 CUL4B RBBP8 FOS ZDBF2 LBP TEX15 ASXL3 CBX8 MTSS2 | 2.98e-06 | 432 | 197 | 16 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BPTF ZFYVE9 CSRNP2 SEC24B BRD1 KNL1 APC ICE1 VPS54 FANCM SIRT1 ANKRD17 DEPDC5 QSER1 FGD6 MTSS2 SOS1 | 2.17e-05 | 564 | 197 | 17 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | MYC TSHZ2 GATA6 SIK1 PTCH1 BRCA1 GLI2 NXF3 SPATS2 ARHGAP20 WNK3 CUL4B RBBP8 SOBP FOS ZDBF2 LBP TEX15 ASXL3 CBX8 MTSS2 | 4.39e-05 | 849 | 197 | 21 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | MYC GATA6 SIK1 NXF3 ARHGAP20 WNK3 CUL4B FOS ZDBF2 LBP TEX15 ASXL3 CBX8 MTSS2 | 6.02e-05 | 436 | 197 | 14 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SP2 KIF1B PEX1 RTN3 SRPK1 PTCH1 BPTF HEG1 SALL1 CSRNP2 BRCA1 FGD4 BRD1 CPLANE1 WNK3 KNL1 GAREM1 CUL4B ANK2 APC ZDBF2 VPS54 FANCM NCKAP5L SIRT1 CELSR1 TTLL4 ARHGAP33 | 6.91e-05 | 1370 | 197 | 28 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#3 | ARHGAP24 HEG1 CSRNP2 KCTD16 KXD1 SPATS2 ARHGAP20 CPLANE1 GAREM1 HECTD3 SLURP1 ZDBF2 ARMC9 LRRK1 NCKAP5L EDA2R CBX8 TCTN2 | 9.22e-05 | 697 | 197 | 18 | ratio_EB-blastocyst_vs_EB-fibro_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HDAC9 SETD1A STRA8 KIF1B GATA6 ANKHD1 FBXO30 RNF157 HEG1 MAST4 BRCA1 SCAPER HERC1 CPLANE1 TEX15 SIRT1 ANKRD17 DEPDC5 GREB1 | 1.18e-04 | 776 | 197 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-08 | 186 | 201 | 10 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 PASK SALL1 BRCA1 FGFR2 KNL1 NUP35 GREB1 ARHGAP33 EVI5L | 2.72e-08 | 200 | 201 | 10 | 691b3edf7d8449556e8bf611662eb85772959f0f |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 PASK SALL1 BRCA1 FGFR2 KNL1 NUP35 GREB1 ARHGAP33 EVI5L | 2.72e-08 | 200 | 201 | 10 | 4e077aa7faddcebdfc54667f8b3990704441005b |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 PASK SALL1 BRCA1 FGFR2 KNL1 NUP35 GREB1 ARHGAP33 EVI5L | 2.72e-08 | 200 | 201 | 10 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | BRIP1 PASK SALL1 BRCA1 FGFR2 KNL1 NUP35 GREB1 ARHGAP33 EVI5L | 2.72e-08 | 200 | 201 | 10 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-07 | 189 | 201 | 9 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | HDAC9 ARHGAP24 MEF2C EIF2AK3 SFMBT1 MARCHF8 LRRK1 IGHM SIPA1L1 | 2.17e-07 | 190 | 201 | 9 | 1e85ee686ff6dd27c69415d524d54fa825b1daad |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-07 | 193 | 201 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-07 | 193 | 201 | 9 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-07 | 195 | 201 | 9 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-07 | 195 | 201 | 9 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.34e-07 | 200 | 201 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-07 | 166 | 201 | 8 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 9.96e-07 | 168 | 201 | 8 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-06 | 171 | 201 | 8 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 177 | 201 | 8 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 177 | 201 | 8 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 177 | 201 | 8 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 182 | 201 | 8 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 182 | 201 | 8 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-06 | 185 | 201 | 8 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-06 | 185 | 201 | 8 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 2.13e-06 | 186 | 201 | 8 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-06 | 187 | 201 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-06 | 187 | 201 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 188 | 201 | 8 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-06 | 189 | 201 | 8 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-06 | 189 | 201 | 8 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.50e-06 | 190 | 201 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 201 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 201 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 192 | 201 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.92e-06 | 194 | 201 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | Healthy_donor-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.92e-06 | 194 | 201 | 8 | bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 195 | 201 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-06 | 195 | 201 | 8 | 0b0615553b9a1b60d666d074ce4260919e2d5642 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.27e-06 | 197 | 201 | 8 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | Transverse-T_cell-Treg|T_cell / Region, Cell class and subclass | 3.27e-06 | 197 | 201 | 8 | b7a1637e4baadd657f6279f4aa96cd590c9cd8c9 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-06 | 139 | 201 | 7 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-06 | 199 | 201 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.66e-06 | 200 | 201 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.66e-06 | 200 | 201 | 8 | 2fb3cf5c7a03c3874390a111bba15203599d4859 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.66e-06 | 200 | 201 | 8 | 4c8007a158f0f6b6fa259b25d2387b648bb2fc0d | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.38e-06 | 160 | 201 | 7 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 168 | 201 | 7 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 168 | 201 | 7 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 168 | 201 | 7 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 171 | 201 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 174 | 201 | 7 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 174 | 201 | 7 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 174 | 201 | 7 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 1.50e-05 | 175 | 201 | 7 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.50e-05 | 175 | 201 | 7 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 176 | 201 | 7 | aab9603b7943b7f7243eb6190ebba998566196f3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 177 | 201 | 7 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 177 | 201 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 178 | 201 | 7 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 178 | 201 | 7 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 180 | 201 | 7 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 180 | 201 | 7 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 181 | 201 | 7 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 181 | 201 | 7 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 181 | 201 | 7 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 181 | 201 | 7 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.86e-05 | 181 | 201 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.93e-05 | 182 | 201 | 7 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.00e-05 | 183 | 201 | 7 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.00e-05 | 183 | 201 | 7 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 185 | 201 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-05 | 185 | 201 | 7 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-05 | 185 | 201 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 185 | 201 | 7 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 2.15e-05 | 185 | 201 | 7 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.22e-05 | 186 | 201 | 7 | 153c8b2fd8a6e2141ca97c626f82e5f081f3180a | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.22e-05 | 186 | 201 | 7 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.30e-05 | 187 | 201 | 7 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.30e-05 | 187 | 201 | 7 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-05 | 188 | 201 | 7 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-05 | 188 | 201 | 7 | 0da6d6d3c28e9d99159b1a24a345a2250e8e1995 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.38e-05 | 188 | 201 | 7 | 9acb7a95e3095f15918a5d094107d1d565a42842 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.46e-05 | 189 | 201 | 7 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 190 | 201 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.55e-05 | 190 | 201 | 7 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 190 | 201 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 2.55e-05 | 190 | 201 | 7 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-05 | 190 | 201 | 7 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | Control-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.63e-05 | 191 | 201 | 7 | 33fce8e086601e636e8c6ef2ab58fcfdd52af369 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.63e-05 | 191 | 201 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 192 | 201 | 7 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-05 | 193 | 201 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-CD4+_Tcm|World / disease stage, cell group and cell class | 2.81e-05 | 193 | 201 | 7 | be0370b2f0093ad0b9d876297bd196d0160f3d99 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 2.81e-05 | 193 | 201 | 7 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 193 | 201 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-05 | 193 | 201 | 7 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 194 | 201 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.91e-05 | 194 | 201 | 7 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| Computational | Neighborhood of NCAM1 | 7.07e-05 | 127 | 117 | 8 | GCM_NCAM1 | |
| Computational | Neighborhood of GSPT1 | RALGAPA1 SETD1A CSRNP2 CPLANE1 HECTD3 ATG2B MTMR4 ZNF512 EVI5L | 9.16e-05 | 169 | 117 | 9 | GCM_GSPT1 |
| Computational | Neighborhood of RAN | RALGAPA1 KIF1B FBXO30 CSRNP2 ATG2B GABBR2 MTMR4 ANKRD17 ZNF512 | 2.81e-04 | 196 | 117 | 9 | GCM_RAN |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A | EPOR MAST4 ACKR2 MAGEC1 CPLANE1 SLC43A1 TEX15 TTLL4 GREB1 ELL AHNAK2 MTSS2 | 1.76e-07 | 197 | 199 | 12 | 2318_UP |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | BRIP1 RAD54L2 HOXA1 PASK MAST4 FGFR1 SLC43A1 ARMC9 GABBR2 ELL ZC3HAV1 | 1.24e-06 | 195 | 199 | 11 | 4502_DN |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | SP2 PASK ACKR2 BAHCC1 DUSP7 APC TEX15 MTHFR TTLL4 QSER1 MTSS2 | 1.44e-06 | 198 | 199 | 11 | 5862_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | SETD1A GATA6 AHDC1 HEG1 ZFYVE9 BAHCC1 CUL4B APC NCOR2 PRICKLE3 ARHGAP33 | 1.51e-06 | 199 | 199 | 11 | 2683_DN |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | RALGAPA1 SETD1A PER1 IKZF1 PTCH1 PHC3 HEG1 ZFYVE9 NR1D2 BAHCC1 ZNF592 | 1.51e-06 | 199 | 199 | 11 | 2257_DN |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; PC3; HT_HG-U133A | EPOR BRIP1 SQLE PER1 FGFR1 SOBP APC SLC1A1 CELSR1 KDM4A VPS13B | 1.51e-06 | 199 | 199 | 11 | 7258_DN |
| Drug | AC1L1BWR | 4.60e-06 | 76 | 199 | 7 | CID000001642 | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.57e-06 | 185 | 199 | 10 | 6243_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 7.39e-06 | 191 | 199 | 10 | 4791_UP | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 8.10e-06 | 193 | 199 | 10 | 4225_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | EPOR PER1 MAST4 FGD1 FGFR1 SLC43A1 APC GABBR2 ARHGAP33 AHNAK2 | 8.47e-06 | 194 | 199 | 10 | 3861_DN |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | EPOR SETD1A BRCA1 FGFR1 HTR1E LRIG1 PRICKLE3 SIPA1L1 ZNF335 ELL | 8.87e-06 | 195 | 199 | 10 | 6510_DN |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | PER1 RAD54L2 FGFR2 C11orf16 NCOR2 PRICKLE3 ZNF592 MTHFR DYRK1B AHNAK2 | 8.87e-06 | 195 | 199 | 10 | 4124_UP |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A | TNFRSF6B HOXA1 HEG1 CPLANE1 BAHCC1 ARMC9 LRRK1 GABBR2 NCOR2 ELL | 9.27e-06 | 196 | 199 | 10 | 7400_UP |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 9.27e-06 | 196 | 199 | 10 | 6934_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | SLC22A17 PASK FGFR1 APC LRRK1 GABBR2 PRICKLE3 MTHFR ELL ZC3HAV1 | 9.70e-06 | 197 | 199 | 10 | 5100_DN |
| Drug | Isometheptene mucate; Up 200; 8.2uM; PC3; HT_HG-U133A | PADI4 IKZF1 PHC3 HEG1 TACR1 CPLANE1 GABBR2 C11orf16 DEPDC5 ELL | 9.70e-06 | 197 | 199 | 10 | 5082_UP |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | IKZF1 RAD54L2 PASK ZFYVE9 APC DEPDC5 BSCL2 ELL ARHGAP33 TCTN2 | 1.01e-05 | 198 | 199 | 10 | 2139_DN |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; HL60; HT_HG-U133A | PADI4 AHDC1 HROB FGFR2 GABBR2 PRICKLE3 MTHFR DEPDC5 CBX8 MTSS2 | 1.01e-05 | 198 | 199 | 10 | 3053_DN |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.01e-05 | 198 | 199 | 10 | 5835_DN | |
| Drug | glyphosate | 2.07e-05 | 215 | 199 | 10 | CID000003496 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.14e-05 | 172 | 199 | 9 | 2330_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.06e-05 | 180 | 199 | 9 | 4541_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.20e-05 | 181 | 199 | 9 | 2403_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 3.64e-05 | 184 | 199 | 9 | 2691_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 4.13e-05 | 187 | 199 | 9 | 6978_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | RALGAPA1 TNFRSF6B PTCH1 MARCHF8 PCLO MTHFR DEPDC5 GREB1 ARHGAP33 | 4.13e-05 | 187 | 199 | 9 | 5233_UP |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 4.49e-05 | 189 | 199 | 9 | 2800_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A | 4.67e-05 | 190 | 199 | 9 | 3041_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 4.67e-05 | 190 | 199 | 9 | 1835_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A | 4.67e-05 | 190 | 199 | 9 | 6680_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.87e-05 | 191 | 199 | 9 | 1057_DN | |
| Drug | curdlan | 4.92e-05 | 109 | 199 | 7 | ctd:C038459 | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 5.07e-05 | 192 | 199 | 9 | 3400_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | EPOR RAD54L2 TNFRSF21 FGFR1 BAHCC1 PRICKLE3 GREB1 TCTN2 AHNAK2 | 5.28e-05 | 193 | 199 | 9 | 3614_DN |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 5.49e-05 | 194 | 199 | 9 | 1310_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 4817_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 5455_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; HL60; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 1271_UP | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 1267_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 3503_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 5.72e-05 | 195 | 199 | 9 | 4433_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2056_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 6786_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2322_UP | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2263_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 4407_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 1708_UP | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2706_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 5483_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; HL60; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 2516_UP | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 6311_UP | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 4478_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 2267_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 1485_UP | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 5226_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 2772_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 3265_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | IKZF1 TNFRSF21 SLC22A17 FGFR2 BAHCC1 MARCHF8 C11orf16 LRIG1 MTSS2 | 6.19e-05 | 197 | 199 | 9 | 3228_DN |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | PADI4 TNFRSF21 FGFR2 NR1D2 LRRK1 GABBR2 NCOR2 PRICKLE3 MTSS2 | 6.19e-05 | 197 | 199 | 9 | 2673_DN |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A | RALGAPA1 SLC22A17 FGD1 FGFR1 CAST TEX15 MTHFR SIPA1L1 ARHGAP33 | 6.19e-05 | 197 | 199 | 9 | 2826_UP |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A | TNFRSF6B RAD54L2 MAST4 FGFR2 PCLO SLC43A1 GABBR2 DEPDC5 TCTN2 | 6.43e-05 | 198 | 199 | 9 | 3632_DN |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; HL60; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 2356_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 4620_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 3676_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; HL60; HG-U133A | 6.43e-05 | 198 | 199 | 9 | 2029_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 5870_UP | |
| Drug | butein; Down 200; 10uM; MCF7; HG-U133A | 6.43e-05 | 198 | 199 | 9 | 607_DN | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 5617_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 2302_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 4213_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 2303_UP | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; HL60; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 3095_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | TNFRSF6B GATA6 MEF2C PASK SCAPER MTHFR ARHGAP33 TCTN2 ZC3HAV1 | 6.69e-05 | 199 | 199 | 9 | 2449_DN |
| Drug | Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; HL60; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 3066_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | EPOR ARHGAP24 RAD54L2 NFATC1 SCAPER FGFR1 FGFR2 SLC43A1 VPS13B | 6.69e-05 | 199 | 199 | 9 | 1509_UP |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; PC3; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 6355_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 6654_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 6690_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.95e-05 | 200 | 199 | 9 | 4489_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | SETD1A SIK1 TNFRSF21 ZFYVE9 SCAPER NR1D2 HTR1E PRICKLE3 ARHGAP33 | 6.95e-05 | 200 | 199 | 9 | 1692_UP |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 6.95e-05 | 200 | 199 | 9 | 643_DN | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.95e-05 | 200 | 199 | 9 | 4505_DN | |
| Drug | vofopitant | 7.60e-05 | 2 | 199 | 2 | ctd:C103207 | |
| Drug | SU4984 | 7.60e-05 | 2 | 199 | 2 | DB02058 | |
| Drug | substance P-saporin | 7.60e-05 | 2 | 199 | 2 | ctd:C468274 | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.29e-04 | 170 | 199 | 8 | 965_UP | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | PADI4 TAGAP ITPRID2 DTNBP1 HOXA1 BPTF SALL1 CSRNP2 BRCA1 MAP3K9 EIF2AK3 GRWD1 TEX15 MAGEE1 SIRT1 CELSR1 ANKRD17 COIL EVI5L | 1.39e-04 | 834 | 199 | 19 | ctd:C513635 |
| Drug | Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.64e-04 | 176 | 199 | 8 | 3102_UP | |
| Drug | Ciguatoxins | MYC SQLE PER1 PEX1 SIK1 DTNBP1 PHC3 CDC40 BRPF1 GAREM1 SFMBT1 RBBP8 FOS DUSP7 BAG3 LBP NUP35 LRIG1 TNFRSF1B | 1.65e-04 | 845 | 199 | 19 | ctd:D002922 |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.92e-04 | 180 | 199 | 8 | 1477_UP | |
| Drug | Anisomycin [22862-76-6]; Down 200; 15uM; HL60; HT_HG-U133A | 2.15e-04 | 183 | 199 | 8 | 1304_DN | |
| Drug | Smoke | GATA6 PTCH1 MEF2C HOXA1 ZNF469 MAST4 FGFR2 EIF2AK3 FOS PCLO LAMA4 SPECC1 SIRT1 CELSR1 IGHM ELF1 FOXP1 GREB1 FGD6 GLIS1 | 2.20e-04 | 937 | 199 | 20 | ctd:D012906 |
| Drug | phenylalanyl-prolyl-arginine methyl chloride | 2.27e-04 | 3 | 199 | 2 | ctd:C020924 | |
| Drug | pivalic anhydride | 2.27e-04 | 3 | 199 | 2 | CID000015234 | |
| Drug | estrone benzoate | 2.27e-04 | 3 | 199 | 2 | ctd:C024552 | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.31e-04 | 185 | 199 | 8 | 5072_UP | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.31e-04 | 185 | 199 | 8 | 6286_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.31e-04 | 185 | 199 | 8 | 5225_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HG-U133A | 2.40e-04 | 186 | 199 | 8 | 432_UP | |
| Disease | neuroimaging measurement | HDAC9 KIF1B PTCH1 GATAD2B ZIC4 ZNF469 MAST4 CSRNP2 BRCA1 FGFR2 TACC3 EIF2AK3 BAHCC1 PKDCC APC ARMC9 CELSR1 FOXP1 SSH2 QSER1 FGD6 ICA1L CBX8 | 8.58e-07 | 1069 | 197 | 23 | EFO_0004346 |
| Disease | Cleft upper lip | 6.04e-06 | 39 | 197 | 5 | C0008924 | |
| Disease | Mental Depression | HDAC9 DTNBP1 BRCA1 FGFR1 TACR1 FGFR2 PCLO SLC1A1 MTHFR TNFRSF1B | 8.81e-06 | 254 | 197 | 10 | C0011570 |
| Disease | cortical surface area measurement | HDAC9 ATG13 KIF1B PTCH1 MEF2C GATAD2B ZIC4 HOXB1 ZNF469 MAST4 FGFR1 FGFR2 TACC3 BRD1 PKDCC APC CELSR1 LRIG1 RP1L1 FOXP1 SSH2 QSER1 FGD6 SOS1 | 1.20e-05 | 1345 | 197 | 24 | EFO_0010736 |
| Disease | white matter microstructure measurement | PTCH1 ANKHD1 BPTF MAST4 NFATC1 SCAPER CCDC157 ARMC9 TTLL4 SSH2 ICA1L SOS1 | 1.36e-05 | 390 | 197 | 12 | EFO_0005674 |
| Disease | Depressive disorder | HDAC9 DTNBP1 BRCA1 FGFR1 TACR1 FGFR2 PCLO SLC1A1 MTHFR TNFRSF1B | 2.68e-05 | 289 | 197 | 10 | C0011581 |
| Disease | Congenital neurologic anomalies | 3.40e-05 | 10 | 197 | 3 | C0497552 | |
| Disease | Holoprosencephaly sequence | 3.40e-05 | 10 | 197 | 3 | cv:C0079541 | |
| Disease | Cranioschisis | 3.40e-05 | 10 | 197 | 3 | C0265541 | |
| Disease | physical activity measurement | 4.28e-05 | 245 | 197 | 9 | EFO_0008002 | |
| Disease | JACKSON-WEISS SYNDROME | 4.43e-05 | 2 | 197 | 2 | C0795998 | |
| Disease | FGFR2-related craniosynostosis | 4.43e-05 | 2 | 197 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 4.43e-05 | 2 | 197 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 4.43e-05 | 2 | 197 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 4.43e-05 | 2 | 197 | 2 | C2931888 | |
| Disease | familial adenomatous polyposis 1 (implicated_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:0080409 (implicated_via_orthology) | |
| Disease | Jackson-Weiss syndrome | 4.43e-05 | 2 | 197 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 4.43e-05 | 2 | 197 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 4.43e-05 | 2 | 197 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 4.43e-05 | 2 | 197 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 4.43e-05 | 2 | 197 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 4.43e-05 | 2 | 197 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | Intellectual Disability | RALGAPA1 SETD1A APC2 MEF2C BPTF BRCA1 SCAPER FGFR2 APC ARMC9 MTF1 ZNF335 | 5.14e-05 | 447 | 197 | 12 | C3714756 |
| Disease | Pancreatic Neoplasm | 5.81e-05 | 100 | 197 | 6 | C0030297 | |
| Disease | Squamous cell carcinoma of lung | 5.99e-05 | 32 | 197 | 4 | C0149782 | |
| Disease | Malignant neoplasm of pancreas | 6.49e-05 | 102 | 197 | 6 | C0346647 | |
| Disease | Autistic Disorder | 6.97e-05 | 261 | 197 | 9 | C0004352 | |
| Disease | Benign tumor of pancreas | 7.98e-05 | 13 | 197 | 3 | C0347284 | |
| Disease | MYELODYSPLASTIC SYNDROME | 8.70e-05 | 67 | 197 | 5 | C3463824 | |
| Disease | prostate cancer (is_marker_for) | 8.94e-05 | 156 | 197 | 7 | DOID:10283 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | HDAC9 PTCH1 GATAD2B ZIC4 BPTF MAST4 TACC3 BAHCC1 PKDCC FOXP1 SSH2 FGD6 CBX8 | 9.10e-05 | 550 | 197 | 13 | EFO_0004346, EFO_0004464 |
| Disease | Craniofacial dysostosis type 1 | 1.32e-04 | 3 | 197 | 2 | C2931196 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 1.32e-04 | 3 | 197 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 1.32e-04 | 3 | 197 | 2 | C0220658 | |
| Disease | Polydactyly | 1.39e-04 | 117 | 197 | 6 | C0152427 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.49e-04 | 75 | 197 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Lobar Holoprosencephaly | 1.54e-04 | 16 | 197 | 3 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 1.54e-04 | 16 | 197 | 3 | C0751617 | |
| Disease | Cleft palate, isolated | 1.77e-04 | 42 | 197 | 4 | C1837218 | |
| Disease | cortical thickness | HDAC9 LHFPL4 PTCH1 MEF2C GATAD2B ZIC4 ZNF469 MAST4 FGFR1 TACC3 PKDCC SPECC1 CELSR1 MTHFR FOXP1 SSH2 QSER1 ELL CBX8 | 1.81e-04 | 1113 | 197 | 19 | EFO_0004840 |
| Disease | Benign neoplasm of stomach | 1.86e-04 | 17 | 197 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.86e-04 | 17 | 197 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.86e-04 | 17 | 197 | 3 | C0154060 | |
| Disease | Childhood Medulloblastoma | 1.94e-04 | 43 | 197 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.94e-04 | 43 | 197 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 1.94e-04 | 43 | 197 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.94e-04 | 43 | 197 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.94e-04 | 43 | 197 | 4 | C0278876 | |
| Disease | Malignant Head and Neck Neoplasm | 2.12e-04 | 44 | 197 | 4 | C0278996 | |
| Disease | electrocardiography | ARHGAP24 GATA6 MAST4 FGFR1 FGFR2 SFMBT1 BAG3 ARMC9 LRIG1 ZNF592 SIPA1L1 FOXP1 | 2.51e-04 | 530 | 197 | 12 | EFO_0004327 |
| Disease | Pancreatic carcinoma | 2.62e-04 | 19 | 197 | 3 | C0235974 | |
| Disease | TWIST1-related craniosynostosis | 2.64e-04 | 4 | 197 | 2 | cv:C4551902 | |
| Disease | X-linked Aarskog syndrome (implicated_via_orthology) | 2.64e-04 | 4 | 197 | 2 | DOID:6683 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4H (implicated_via_orthology) | 2.64e-04 | 4 | 197 | 2 | DOID:0110192 (implicated_via_orthology) | |
| Disease | mean reticulocyte volume | HDAC9 SETD1A BRIP1 SRPK1 IKZF1 MEF2C ZNF469 TBC1D12 TACC3 MARCHF8 SPECC1 TXNDC11 MTHFR ELF1 FOXP1 | 3.30e-04 | 799 | 197 | 15 | EFO_0010701 |
| Disease | Medulloblastoma | 3.49e-04 | 50 | 197 | 4 | C0025149 | |
| Disease | Joubert syndrome 1 | 3.57e-04 | 21 | 197 | 3 | C4551568 | |
| Disease | Stomach Carcinoma | 3.57e-04 | 21 | 197 | 3 | C0699791 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.57e-04 | 21 | 197 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | nose morphology measurement | 3.92e-04 | 329 | 197 | 9 | EFO_0007843 | |
| Disease | cerebellar volume measurement | 4.06e-04 | 52 | 197 | 4 | EFO_0020864 | |
| Disease | bone disease (implicated_via_orthology) | 4.38e-04 | 5 | 197 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Basal Cell Nevus Syndrome | 4.38e-04 | 5 | 197 | 2 | C0004779 | |
| Disease | Metastatic melanoma | 4.69e-04 | 54 | 197 | 4 | C0278883 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 5.35e-04 | 24 | 197 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | congenital heart disease (is_implicated_in) | 5.35e-04 | 24 | 197 | 3 | DOID:1682 (is_implicated_in) | |
| Disease | Fanconi Anemia | 6.05e-04 | 25 | 197 | 3 | C0015625 | |
| Disease | FEV/FEC ratio | HDAC9 ASXL1 KIF1B GATA6 PTCH1 HOXB1 NFATC1 SCAPER TBC1D12 FGFR1 FGFR2 HERC1 ARHGAP20 BAG3 FAM227B FOXP1 SSH2 FGD6 PHLDB2 | 6.08e-04 | 1228 | 197 | 19 | EFO_0004713 |
| Disease | Craniofacial Abnormalities | 6.51e-04 | 156 | 197 | 6 | C0376634 | |
| Disease | spina bifida (is_implicated_in) | 6.54e-04 | 6 | 197 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | Familial generalized lipodystrophy | 6.54e-04 | 6 | 197 | 2 | C0221032 | |
| Disease | risk-taking behaviour | TSHZ2 PTCH1 ZIC4 BPTF KIRREL3 LRFN5 BAHCC1 IKZF2 TNNI3K RP1L1 FOXP1 ICA1L CBX8 MTSS2 | 6.59e-04 | 764 | 197 | 14 | EFO_0008579 |
| Disease | Acute monocytic leukemia | 6.80e-04 | 26 | 197 | 3 | C0023465 | |
| Disease | wellbeing measurement | PTCH1 GATAD2B BPTF KIRREL3 LRFN5 HERC1 SFMBT1 PCLO VPS54 TEX15 ASXL3 RP1L1 FOXP1 | 8.16e-04 | 692 | 197 | 13 | EFO_0007869 |
| Disease | insomnia measurement | HDAC9 HOXB1 SALL1 UBR5 C3orf70 PRICKLE4 TEX15 TNNI3K ASXL3 FOXP1 | 8.39e-04 | 443 | 197 | 10 | EFO_0007876 |
| Disease | Epilepsy | 8.40e-04 | 109 | 197 | 5 | C0014544 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 8.49e-04 | 28 | 197 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | forced expiratory volume | HDAC9 SETD1A ARHGAP24 PTCH1 FGFR2 EIF2AK3 GAREM1 RBBP8 PKDCC FAM227B NCOR2 FOXP1 FGD6 CBX8 | 8.98e-04 | 789 | 197 | 14 | EFO_0004314 |
| Disease | myeloid neoplasm (is_implicated_in) | 9.11e-04 | 7 | 197 | 2 | DOID:0070004 (is_implicated_in) | |
| Disease | Urogenital Abnormalities | 9.11e-04 | 7 | 197 | 2 | C0042063 | |
| Disease | Craniosynostosis syndrome | 9.11e-04 | 7 | 197 | 2 | cv:C0010278 | |
| Disease | atrial fibrillation | 9.21e-04 | 371 | 197 | 9 | EFO_0000275 | |
| Disease | Malignant neoplasm of breast | EPOR BRIP1 APC2 PER1 BRCA1 SLC10A6 FGFR1 FGFR2 ANK2 FOS MAGEE1 TESK1 SIRT1 PRICKLE3 MTHFR SIPA1L1 VPS13B | 9.22e-04 | 1074 | 197 | 17 | C0006142 |
| Disease | Miller Dieker syndrome | 9.42e-04 | 29 | 197 | 3 | C0265219 | |
| Disease | eosinophil count | IKZF1 BPTF PHC3 SALL1 CFAP92 BRCA1 ACKR2 BAHCC1 IKZF2 HTR1E KIF27 RBBP8 TXNDC11 NCOR2 CELSR1 MTF1 ELF1 FOXP1 TNFRSF1B MUC22 ZC3HAV1 | 1.02e-03 | 1488 | 197 | 21 | EFO_0004842 |
| Disease | Familial aplasia of the vermis | 1.04e-03 | 30 | 197 | 3 | C0431399 | |
| Disease | aspartate aminotransferase measurement | BRIP1 STRA8 TNFRSF6B IKZF1 PTCH1 BRCA1 KIF27 BAG3 CAST ARMC9 FAM227B NCOR2 ELF1 ELL SOS1 | 1.16e-03 | 904 | 197 | 15 | EFO_0004736 |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.21e-03 | 8 | 197 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 1.26e-03 | 32 | 197 | 3 | EFO_0021870 | |
| Disease | hyperuricemia | 1.38e-03 | 33 | 197 | 3 | EFO_0009104 | |
| Disease | Abnormality of radial ray | 1.38e-03 | 33 | 197 | 3 | C4228778 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.38e-03 | 33 | 197 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 1.39e-03 | 72 | 197 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Bipolar Disorder | DTNBP1 FGFR1 TACR1 FGFR2 BRD1 PCLO SLC1A1 SIRT1 ZNF592 MTHFR | 1.46e-03 | 477 | 197 | 10 | C0005586 |
| Disease | heart function measurement | 1.51e-03 | 34 | 197 | 3 | EFO_0004311 | |
| Disease | retinal detachment (biomarker_via_orthology) | 1.55e-03 | 9 | 197 | 2 | DOID:5327 (biomarker_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | ASXL1 PTCH1 LRFN5 NR1D2 KIF27 PCLO APC ASXL3 SIPA1L1 FOXP1 CBX8 | 1.56e-03 | 566 | 197 | 11 | EFO_0007660, EFO_0008354 |
| Disease | urinary bladder cancer (is_implicated_in) | 1.70e-03 | 76 | 197 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_marker_for) | 1.77e-03 | 257 | 197 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Burkitt Lymphoma | 1.78e-03 | 36 | 197 | 3 | C0006413 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSPASSCSSSEDSEQ | 221 | O60347 | |
| APGTAQASLSSCSES | 336 | O00590 | |
| SSQEALSAPTCSPTS | 11 | Q96CN4 | |
| RECVASLSSSSSSSP | 481 | Q96M60 | |
| ASESSISSSNSPLCD | 851 | O95696 | |
| ISSSNSPLCDSSFNA | 856 | O95696 | |
| GSVSTSSLCSSDNED | 2361 | Q9P281 | |
| FSTSGLEDSCTETSS | 511 | Q92667 | |
| EDSQEVCTTSFSTSP | 246 | O75143 | |
| CNGTVSVASSPSFSA | 516 | P32519 | |
| NGTCSVSSVPTSTSE | 491 | P55199 | |
| SSCGSPNSADTSSDF | 6 | Q99708 | |
| SFSVGISCDQTSSSE | 721 | Q9NZJ5 | |
| ISCDQTSSSESQFSP | 726 | Q9NZJ5 | |
| SSDSADSCDSLNPPT | 31 | Q9H175 | |
| TFCVSDFSTSDPTTE | 241 | P28566 | |
| ICDPSETSSTTNRSS | 116 | Q5T7R7 | |
| GDSSCPTSITQESSF | 271 | Q5M775 | |
| PCSSIESSSEPASTF | 51 | Q9ULG3 | |
| DCEQSPTSSRTSSLG | 2956 | Q9NYQ6 | |
| SSSSSSFQPSPENCR | 1086 | Q5TGY3 | |
| STSSSSTPTEFCRNG | 41 | Q96K78 | |
| CTSTTSSQSEPSEQL | 71 | Q9Y4B4 | |
| SLLTPCSSASNDSSA | 2376 | O75179 | |
| CSSPSSSEDSGINAI | 181 | A6NLC5 | |
| CESSNTSATTTSIQP | 691 | Q12830 | |
| SDSTQTTTPSASCPE | 1636 | Q12830 | |
| SSSVESQITCPTDSG | 561 | Q569K6 | |
| DTCPSSSTASSISSS | 456 | Q9Y463 | |
| DEFSASAKSSPVCST | 231 | Q96BY7 | |
| SSNASCSTESQSRPL | 131 | Q8IXJ9 | |
| ACISETSFSSESPEG | 606 | Q9C0F0 | |
| TSFSSESPEGACTSL | 611 | Q9C0F0 | |
| TPASLETTFCSEVSS | 641 | Q9C0F0 | |
| TNNSSPDSFASTCSN | 136 | Q5SZJ8 | |
| SSLSCSPIGDSTQVS | 231 | Q2KHR3 | |
| CLSIAGPSSRSTDSS | 206 | Q9UPP5 | |
| TCSSQDSSTTTSALP | 616 | Q96NI6 | |
| QADCPSESFSSSSSL | 2836 | Q01484 | |
| SSAPEDCTSFSINAS | 31 | Q9UM07 | |
| SRKSASSCDVSSSPS | 491 | O75140 | |
| TRSSCSSGDDSVFSP | 786 | P21802 | |
| DRSPVCTTFSDTSSN | 281 | Q9H4D5 | |
| PSGETATSSLCSVTN | 241 | Q99102 | |
| CSGPATVNNSSDTES | 736 | Q9Y618 | |
| SGSESSKDSSRCSTP | 21 | P42898 | |
| SSNCSCATSELRETP | 756 | Q96RG2 | |
| SESSGRPTVTASSCS | 146 | P18428 | |
| RPTVTASSCSSDIAD | 151 | P18428 | |
| PTTTAAAAVSCTESD | 66 | P43366 | |
| SEVSPSTESSCSNFI | 26 | Q9BZ81 | |
| FQSSLQSPVSICSSS | 621 | O60732 | |
| FQSSLQSPVSICSSS | 736 | O60732 | |
| FSSSASVDRNPSKCS | 416 | Q9HCI5 | |
| DIRFTCSAASSSSSP | 511 | Q96JA1 | |
| NCAPGSSSSSSSDEA | 291 | Q9HCH0 | |
| ASTCSSSLFPALEST | 221 | Q4ZG55 | |
| PTENTVFASCSADAS | 271 | Q9BQ67 | |
| STSSCDSQSEASSPQ | 311 | Q68DU8 | |
| EASSSRCSSASPAGD | 11 | P01100 | |
| SGAIESTAPACTSSS | 426 | Q6A163 | |
| NTACTTGSETSTPSS | 1466 | E2RYF6 | |
| SSPASSSSVPFSTDC | 1861 | Q38SD2 | |
| ESSFSSATLTPSSTC | 1621 | O60333 | |
| STPESCVSSSSAIIA | 701 | Q7Z3E5 | |
| SSNSEGSCSVFSSPK | 3686 | Q2LD37 | |
| EDSSTSGASCSKSRP | 1786 | Q8IYD8 | |
| SSPSDAADLSSVCTG | 906 | Q15751 | |
| YSSTCPAESSTNTTQ | 46 | O75387 | |
| ASFLPCSSQSSEESS | 481 | Q8WYA1 | |
| ASSCSLQSSDSVPVG | 221 | Q9UGM5 | |
| TCVSPSSSNFDESLN | 316 | Q86VH2 | |
| SASSEQDNPSTSGCS | 111 | O15534 | |
| SSVSSVCTTDSSSPI | 2186 | Q9Y6V0 | |
| TSEQSTGSCDTSPDT | 126 | Q9BQD3 | |
| ASETCQSVSECSSPT | 361 | Q765P7 | |
| PSSSSTCTDSATRDI | 296 | Q96EV8 | |
| SPTTDSCDGNASDSS | 141 | Q96M96 | |
| TSPVTAEFSSSVSGC | 681 | Q9H706 | |
| SLDLTTTCVSSSAPS | 251 | Q9H334 | |
| LSPASSLSSRSCNSE | 171 | O95644 | |
| VSVCSKESPSSSSES | 236 | P38432 | |
| FTSTGCSTDINLSTP | 711 | O75164 | |
| CSSSVAESSSPLRNF | 411 | Q6ZU52 | |
| SFSRTSITPSSQDIC | 66 | Q5T0T0 | |
| SRTPSSCSSSLDSIK | 1841 | Q8NG31 | |
| NSSCSTPSRTSSGLF | 321 | Q8N3J3 | |
| AGRSPVDSLSSCSSS | 416 | Q06413 | |
| ATPTQLSSSSNCLSD | 336 | P10070 | |
| SPTTVSSSASVNSCA | 976 | Q9ULI3 | |
| QSSSSVPCQRTTSSA | 301 | Q8WXI9 | |
| CRSPASETSSPAQTF | 191 | P49639 | |
| REASPSNSCQDSTDT | 386 | Q13422 | |
| TCRGSFTDFSTIPSS | 76 | Q7Z7J7 | |
| REASPSNSCLDSTDS | 396 | Q9UKS7 | |
| FSQATSESSSVCSGP | 1106 | P28290 | |
| PVVSSSSSSSCQSAA | 196 | Q8NDX5 | |
| SACDTSSPLTRTSSD | 616 | Q9NYA4 | |
| SERNGTSSTCQDSPE | 116 | Q9BX63 | |
| DSESCSSSPSSSSSE | 541 | O43900 | |
| DTPFSTCSSSSDSEP | 296 | Q2TBC4 | |
| TCSSSSDSEPEGFFL | 301 | Q2TBC4 | |
| PAGSCESLSSSSSSE | 671 | O14559 | |
| STSSCEISLPENSNS | 556 | Q8N264 | |
| ENSNSCRSSTTTCPE | 566 | Q8N264 | |
| TSVSEDCSGLSSQSD | 1376 | P38398 | |
| PTSTSSNSDDCSKNT | 516 | Q92908 | |
| RCSSVSSLGSFESPS | 1161 | O95996 | |
| GDASDQSTCTSPEAS | 281 | P14653 | |
| ANADTSTPTDCSPDT | 1606 | Q9Y2F5 | |
| ATTNEERSCSSPAVS | 1881 | Q9Y2F5 | |
| PPASSTSTSSTCRAE | 131 | Q9HC52 | |
| LVSCENSPSDTSSVA | 11 | P01871 | |
| CVFPTADSAVSLSSS | 2801 | Q9H799 | |
| STDCVDFAPSAAATS | 126 | A8K830 | |
| PDTRSSTCSSGEDSV | 781 | P11362 | |
| DCSASTVSASPEAPT | 726 | Q8NHY3 | |
| ATCSSSSPEASRTQE | 1581 | Q5JV73 | |
| SSSCTLSASTERPDG | 251 | Q9H1R2 | |
| GTAACTSTSSQNDPE | 111 | Q14534 | |
| CETNVDSSSSPSSSP | 186 | Q16829 | |
| GDLDSCPSTTETSQN | 656 | P20810 | |
| TSCISSSASSSLETP | 46 | Q6UX82 | |
| SECVDSTDNSSKPSS | 1046 | O15021 | |
| ISDTESFSNDPCTSV | 226 | O75899 | |
| SEASSCSSALASKPS | 401 | P19235 | |
| SFLDTQCDSSVSSSG | 721 | Q8IZU9 | |
| SSCKEESASSVTPSS | 271 | Q8IX15 | |
| PSSGNSTRSDSSACV | 521 | Q9UKV0 | |
| ASSSPCASSDVTSII | 76 | Q8NBF1 | |
| DCVASSDGTSKPSSS | 316 | Q8TB52 | |
| SGSSSTSEFTQECQT | 356 | Q8NDH6 | |
| RTDCDSSTTSLCSFP | 71 | Q96G97 | |
| SSTTSLCSFPVANVS | 76 | Q96G97 | |
| SQSPAASDCSSSSSS | 171 | O95817 | |
| ASDCSSSSSSASLPS | 176 | O95817 | |
| SASSSVASQGFPSTC | 166 | O95487 | |
| TGSTASSEITPAQSC | 231 | Q9BY12 | |
| TASSSVLSSPAADCG | 636 | Q9NSC2 | |
| GTSSDLSSQCLSAPS | 1141 | O43933 | |
| RDSASPSTSSFCLGV | 91 | Q13620 | |
| SSSSATLPVTFRCAE | 331 | P43005 | |
| ANSSSTETPSNLDSC | 1021 | P80192 | |
| TETPSNLDSCFASSS | 1026 | P80192 | |
| SSSDCTTESSRTFPE | 1726 | Q5THK1 | |
| ASITSASQTFSVTPC | 1626 | Q16363 | |
| SSDRCALSSPSLAFT | 251 | Q8NFH5 | |
| STEASCSPTTTEGTS | 781 | Q685J3 | |
| STEACSSPTTSEGTS | 1371 | Q685J3 | |
| SSASSPASCHSEGSE | 16 | Q14995 | |
| TTRDSPSASVDTCTF | 61 | Q9P2F6 | |
| CADSFVSSSSSQPVS | 46 | O95197 | |
| DLDCSSSSQSPGSSE | 151 | Q9Y6A5 | |
| SCSPNTSVSFISTVA | 541 | Q8IYR2 | |
| DQSSCTGTPLSSTIS | 491 | Q96PX1 | |
| STASSSTEYQCIPDS | 401 | Q504Y2 | |
| ETDNVCGTLPSFSSS | 206 | O75509 | |
| SSSSLDASSDSSPVA | 461 | Q8N103 | |
| SAASRVATSTDPSCS | 46 | Q8WUG5 | |
| SSSSTLPSSCEQSRQ | 686 | Q14872 | |
| DSSSPKSCASQDSSA | 201 | P01106 | |
| KSCASQDSSAFSPSS | 206 | P01106 | |
| TPSSLDLTSNCSSRS | 376 | P25103 | |
| SGSESDSDSESSRCP | 16 | O60508 | |
| DSISSPSNSEETCFV | 286 | P98174 | |
| TLSCQSPESTSSTRD | 696 | Q13635 | |
| ETSSCLDSLSSKSSP | 101 | O43166 | |
| CRNSPSNLSSSSDTG | 1146 | O43166 | |
| TASPAEGTSSDSCLT | 496 | A0A0B4J2F2 | |
| TASPAEGTSSDSCLT | 496 | P57059 | |
| SEDDVLSSSSCGSNS | 661 | Q96EB6 | |
| RSCSSSCVATDPDSI | 71 | P55000 | |
| CSTLTSSTASPSTDS | 176 | Q9C0D5 | |
| STSQETDSCTPITSE | 406 | Q96SB4 | |
| ISACSPDNISSASTS | 1016 | Q86SQ0 | |
| PASGASSTTDVCSVF | 1091 | Q07889 | |
| TPCSQDTSFSSSRQD | 241 | O15047 | |
| NSAFCLASTSPTSSA | 86 | P0CG40 | |
| EVPSTSSSSSVLASC | 261 | Q7Z7C7 | |
| DCSLPRSSSDSESSS | 991 | P55201 | |
| LSTIPLSSSECSSFE | 4731 | Q8IVF2 | |
| LGDSICFSPSISSTT | 371 | A6NIR3 | |
| SNSSSQTTECLTPES | 1011 | Q8IWZ3 | |
| FATESTPDGFSCSSS | 1491 | P25054 | |
| TPDGFSCSSSLSALS | 1496 | P25054 | |
| PLAVSSSSSSSCEQD | 331 | Q9NQ32 | |
| AVSAETTPSATRSCS | 186 | Q8N0U2 | |
| SDASAASSSTCASPP | 396 | Q86XZ4 | |
| QEGDSTNFTCSFPSS | 36 | A0A0B4J272 | |
| STLTEREPSSSSLCS | 371 | Q6GYQ0 | |
| DSSFSDCLSSPSSSL | 131 | Q6ZNA4 | |
| TPSTTSSPCASEADS | 11 | Q76I76 | |
| ERCSQDSASPASSTG | 446 | Q8IWN7 | |
| SEGASSTPSTCTSSQ | 621 | Q8IWN7 | |
| PSASTTVSPSDTANC | 326 | A7XYQ1 | |
| EPDENSSSVTSCQAS | 126 | Q8WVD5 | |
| AAATSNTTCSSPASR | 376 | Q02086 | |
| SDSPRSICSDSSSKG | 346 | Q92610 | |
| ESTEEPGNSDSSSSC | 336 | Q6ZV73 | |
| PGNSDSSSSCLTENS | 341 | Q6ZV73 | |
| SSETNFDCDASPQST | 491 | Q9HCK1 | |
| SSSSACPANSSEEEL | 6 | Q3KNW5 | |
| ATDNFISTCSSASQP | 491 | Q15569 | |
| CSPDSTTGSFADSFS | 331 | Q9NRE2 | |
| ETSSSPADSTTSSCL | 2776 | Q96JG9 | |
| DCLSSSPTLATASSA | 31 | Q6PKC3 | |
| PSLSASTSSSCSTAA | 446 | Q86UK7 | |
| DGTATPSLCSKTFST | 136 | Q8N9L1 | |
| TSTCSPSADIGTTTE | 1276 | Q7Z7G8 | |
| SSASESGSQSTCDPL | 2441 | Q7Z7G8 | |
| SCSSSPTQSEISTSL | 736 | Q9UHJ3 | |
| PGTFSNTTSSTDICR | 166 | P20333 | |
| LASASASAERSCTPS | 261 | Q7Z2W4 | |
| SNSASSSEVVPGDCA | 91 | Q9BXT5 | |
| NAEDIISSPSSCSSS | 941 | Q14679 | |
| DCSSTSGFPTQESFT | 221 | Q9HAV5 | |
| SSGSLSPSSSSDCLV | 736 | Q59H18 | |
| ATTFQSSEAPSLLCS | 756 | Q9H4Z2 | |
| SLSGSSSASSCEPVS | 51 | Q96ME7 | |
| SSNETDSFSESPCIL | 106 | Q96GX1 | |
| PTSSDSLASVCSPSQ | 231 | O95405 | |
| PSPASTCSDASSIAS | 611 | O95071 | |
| SVSEPECTTDSSSSK | 551 | Q9P1Q0 | |
| GTFSASSSSSEQCQP | 156 | O95407 | |
| SFSAACETDVSSVTP | 1421 | Q9BYP7 | |
| YETTDALPESSTCSS | 811 | Q5T447 |